SYNOPSYS INC, 10-Q filed on 2/25/2026
Quarterly Report
v3.25.4
COVER - shares
 3 Months Ended
Jan. 31, 2026
Feb. 23, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jan. 31, 2026  
Document Transition Report false  
Entity File Number 000-19807  
Entity Registrant Name SYNOPSYS, INC.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 56-1546236  
Entity Address, Address Line One 675 ALMANOR AVE  
Entity Address, City or Town SUNNYVALE  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 94085  
City Area Code 650  
Local Phone Number 584-5000  
Title of 12(b) Security Common Stock(par value of $0.01 per share)  
Trading Symbol SNPS  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   191,562,027
Amendment Flag false  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q1  
Entity Central Index Key 0000883241  
Current Fiscal Year End Date --10-31  
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Current assets:    
Cash and cash equivalents $ 2,129,572 $ 2,888,030
Short-term investments 73,910 72,929
Total cash, cash equivalents and short-term investments 2,203,482 2,960,959
Accounts receivable, net 1,640,665 1,505,427
Inventories 393,221 365,190
Prepaid and other current assets 1,088,118 1,180,526
Current assets held for sale 48,152 0
Total current assets 5,373,638 6,012,102
Property and equipment, net 676,693 696,693
Operating lease right-of-use assets, net 713,594 702,008
Goodwill 26,880,889 26,899,215
Intangible assets, net 12,289,529 12,679,591
Deferred income taxes 117,386 112,159
Other long-term assets 1,186,199 1,122,693
Total assets 47,237,928 48,224,461
Current liabilities:    
Accounts payable and accrued liabilities 1,304,688 1,326,211
Operating lease liabilities 133,098 128,205
Deferred revenue 2,459,122 2,245,961
Short-term debt 22,117 22,117
Current liabilities held for sale 23,625 0
Total current liabilities 3,942,650 3,722,494
Long-term operating lease liabilities 691,249 680,698
Long-term deferred revenue 420,887 382,557
Long-term debt 10,022,093 13,462,398
Other long-term liabilities 1,613,051 1,649,299
Total liabilities 16,689,930 19,897,446
Stockholders’ equity:    
Preferred stock, $0.01 par value: 2,000 shares authorized; none outstanding 0 0
Common stock, $0.01 par value: 400,000 shares authorized; 191,449 and 185,994 shares outstanding, respectively 1,915 1,860
Capital in excess of par value 20,562,001 18,640,947
Retained earnings 10,380,445 10,315,487
Treasury stock, at cost: 589 and 1,222 shares, respectively (191,851) (398,278)
Accumulated other comprehensive income (loss) (203,683) (232,414)
Total Synopsys stockholders’ equity 30,548,827 28,327,602
Non-controlling interest (829) (587)
Total stockholders’ equity 30,547,998 28,327,015
Total liabilities and stockholders’ equity $ 47,237,928 $ 48,224,461
v3.25.4
CONDENSED CONSOLIDATED BALANCE SHEETS (PARENTHETICAL) - $ / shares
Jan. 31, 2026
Oct. 31, 2025
Jan. 31, 2025
Statement of Financial Position [Abstract]      
Preferred stock, par value (in USD per share) $ 0.01 $ 0.01  
Preferred stock, shares authorized (in shares) 2,000,000 2,000,000  
Preferred stock, shares outstanding (in shares) 0 0  
Common stock, par value (in USD per share) $ 0.01 $ 0.01  
Common stock, shares authorized (in shares) 400,000,000 400,000,000  
Common Stock Shares issued Not Disclosed true   true
Common stock, shares outstanding (in shares) 191,449,000 185,994,000  
Treasury stock, shares (in shares) 589,000 1,222,000  
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Revenue:    
Total revenue $ 2,408,798 $ 1,455,315
Cost of revenue:    
Amortization of acquired intangible assets 248,242 8,596
Total cost of revenue 637,382 269,975
Gross margin 1,771,416 1,185,340
Operating expenses:    
Research and development 714,988 553,216
Sales and marketing 396,375 209,199
General and administrative 182,732 167,086
Amortization of acquired intangible assets 155,993 4,000
Restructuring charges 118,282 0
Total operating expenses 1,568,370 933,501
Operating income 203,046 251,839
Interest expense (162,715) (11,139)
Other income (expense), net 38,722 50,417
Income before income taxes 79,053 291,117
Provision (benefit) for income taxes 14,337 (6,294)
Net income 64,716 297,411
Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (242) 1,728
Net income attributed to Synopsys $ 64,958 $ 295,683
Net income per share attributed to Synopsys:    
Basic (in USD per share) $ 0.34 $ 1.91
Diluted (in USD per share) $ 0.34 $ 1.89
Shares used in computing per share amounts:    
Basic (in shares) 189,593 154,408
Diluted (in shares) 190,762 156,189
Products    
Revenue:    
Total revenue $ 1,693,071 $ 1,196,362
Cost of revenue:    
Cost of revenue 242,402 168,842
Time-based products    
Revenue:    
Total revenue 951,541 828,238
Upfront products    
Revenue:    
Total revenue 741,530 368,124
Maintenance and service    
Revenue:    
Total revenue 715,727 258,953
Cost of revenue:    
Cost of revenue $ 146,738 $ 92,537
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Statement of Comprehensive Income [Abstract]    
Net income $ 64,716 $ 297,411
Other comprehensive income (loss):    
Change in foreign currency translation adjustment 38,533 (28,637)
Change in unrealized gains (losses) on available-for-sale securities, net of tax of $0 for periods presented 74 (42)
Cash flow hedges:    
Deferred gains (losses), net of tax of $3,543 and $11,494, respectively (11,536) (36,448)
Reclassification adjustment on deferred (gains) losses included in net income, net of tax of $(653) and $(1,403), respectively 1,660 3,588
Other comprehensive income (loss), net of tax effects 28,731 (61,539)
Comprehensive income 93,447 235,872
Less: Net income (loss) attributed to non-controlling interest and redeemable non-controlling interest (242) 1,728
Comprehensive income attributed to Synopsys $ 93,689 $ 234,144
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (PARENTHETICAL) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Statement of Comprehensive Income [Abstract]    
Change in unrealized gains (losses) on available-for-sale securities, tax $ 0 $ 0
Deferred gains (losses), tax 3,543 11,494
Reclassification adjustment on deferred (gains) losses included in net income, tax $ (653) $ (1,403)
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
shares in Thousands, $ in Thousands
Total
Private Placement
Total  Synopsys Stockholders’ Equity
Total  Synopsys Stockholders’ Equity
Private Placement
Common Stock
Common Stock
Private Placement
Capital in Excess of Par Value
Capital in Excess of Par Value
Private Placement
Retained Earnings
Treasury Stock
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Beginning balance (in shares) at Oct. 31, 2024         154,112              
Beginning balance at Oct. 31, 2024 $ 8,993,206   $ 8,990,702   $ 1,541   $ 1,211,206   $ 8,984,105 $ (1,025,770) $ (180,380) $ 2,504
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 298,249   295,683           295,683     2,566
Other comprehensive income (loss), net of tax effects (61,539)   (61,539)               (61,539)  
Common stock issued (in shares)         506              
Common stock issued (110,604)   (110,604)   $ 6   (275,413)     164,803    
Stock-based compensation 186,463   185,754       185,754         709
Adjustments to redeemable non-controlling interest (838)   (838)           (838)      
Deconsolidation of non-controlling interest upon the sale of subsidiary (36)   5,634       5,634         (5,670)
Ending balance (in shares) at Jan. 31, 2025         154,618              
Ending balance at Jan. 31, 2025 $ 9,304,901   9,304,792   $ 1,547   1,127,181   9,278,950 (860,967) (241,919) 109
Beginning balance (in shares) at Oct. 31, 2025 185,994       185,994              
Beginning balance at Oct. 31, 2025 $ 28,327,015   28,327,602   $ 1,860   18,640,947   10,315,487 (398,278) (232,414) (587)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                        
Net income 64,716   64,958           64,958     (242)
Other comprehensive income (loss), net of tax effects 28,731   28,731               28,731  
Common stock issued (in shares)         632 4,822            
Common stock issued (131,856) $ 2,000,000 (131,856) $ 2,000,000 $ 6 $ 48 (337,811) $ 1,999,952   205,949    
Common stock issued for prior acquisition (in shares)         1              
Common stock issued for prior acquisition 668   668   $ 1   189     478    
Stock-based compensation $ 258,724   258,724       258,724          
Ending balance (in shares) at Jan. 31, 2026 191,449       191,449              
Ending balance at Jan. 31, 2026 $ 30,547,998   $ 30,548,827   $ 1,915   $ 20,562,001   $ 10,380,445 $ (191,851) $ (203,683) $ (829)
v3.25.4
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Cash flows from operating activities:    
Net income $ 64,716 $ 297,411
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Amortization and depreciation 450,688 47,934
Reduction of operating lease right-of-use assets 36,442 25,473
Amortization of capitalized costs to obtain revenue contracts 19,277 12,466
Stock-based compensation 258,724 186,463
Allowance for credit losses 8,206 9,919
Deferred income taxes (51,776) (139,075)
Other (218) 186
Net changes in operating assets and liabilities, net of effects from acquisitions and dispositions:    
Accounts receivable (128,651) 30,948
Inventories (29,382) (55,852)
Prepaid and other current assets 84,616 (103,567)
Other long-term assets (81,413) (43,494)
Accounts payable and accrued liabilities (37,286) (313,651)
Operating lease liabilities (32,345) (23,102)
Income taxes 17,561 86,992
Deferred revenue 265,115 (96,974)
Net cash provided by (used in) operating activities 856,832 (67,455)
Cash flows from investing activities:    
Proceeds from maturities of short-term investments 3,718 19,684
Proceeds from sales of short-term investments 0 16,411
Purchases of short-term investments (4,503) (37,269)
Purchases of strategic investments (401) (3,288)
Purchases of property and equipment, net (35,320) (40,715)
Proceeds from business divestiture, net of cash divested 0 23,808
Other 0 (611)
Net cash used in investing activities (36,506) (21,980)
Cash flows from financing activities:    
Repayment of debt (3,451,310) (1,289)
Issuances of common stock 12,742 14,417
Payments for taxes related to net share settlement of equity awards (144,597) (124,966)
Common stock issuance for private placement 2,000,000 0
Redemption of redeemable non-controlling interest 0 (30,000)
Net cash used in financing activities (1,583,165) (141,838)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,432 (9,676)
Net change in cash, cash equivalents and restricted cash (759,407) (240,949)
Cash, cash equivalents and restricted cash, beginning of year 2,134,314 3,657,780
Cash, cash equivalents and restricted cash, end of period 2,134,314 3,657,780
Bridge Commitment    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Amortization of bridge financing costs/debt issuance costs 0 10,468
Other Debt Instruments    
Adjustments to reconcile net income to net cash provided by (used in) operating activities:    
Amortization of bridge financing costs/debt issuance costs $ 12,558 $ 0
v3.25.4
Description of Business
 3 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Description of Business Description of Business
Synopsys, Inc. (Synopsys, we, our or us) is the leader in engineering solutions from silicon to systems, enabling customers to rapidly innovate AI-powered products. We deliver trusted and comprehensive solutions spanning silicon design, silicon intellectual property (IP), simulation and analysis (S&A) as well as design services. We partner closely with our customers across a wide range of industries to maximize their R&D capability and productivity, powering innovation today that ignites the ingenuity of tomorrow.
We are a global leader in supplying the mission-critical electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs), also known as chips or silicon, and we are pioneering artificial intelligence (AI) driven chip design across the full-stack EDA suite to improve efficiency and accelerate the design, verification testing and manufacturing of advanced digital and analog chips. We provide software and hardware used to validate the electronic systems that incorporate chips and the software that runs on them, including cloud-based digital design flow to boost chip-design development productivity. We also provide technical services and support to help our customers develop advanced chips and electronic systems.
We are the global leader in engineering S&A software. Our Ansys® solutions portfolio is widely used by engineers, designers, researchers and students across a broad spectrum of industries and academia, including high-tech, aerospace and defense, automotive, energy, industrial equipment, materials and chemicals, consumer products, healthcare and construction. These products enable customers to analyze designs on-premises and/or via the cloud, providing a common platform for fast, efficient and cost-conscious product development, from design concept to final-stage testing, validation and deployment. These products and services are part of our Design Automation segment.
We also offer a broad and comprehensive portfolio of semiconductor IP solutions, which are pre-designed circuits that engineers use as components of larger chip designs to reduce development risk and speed time to market. Our high quality, silicon-proven semiconductor IP includes logic libraries, embedded memories, wired interface IP, memory interface IP, security IP, and embedded processors. To accelerate IP integration and silicon bring-up, our IP Accelerated initiative provides architecture design expertise, customized IP subsystems, hardening, and signal and power integrity analysis. These products and services are part of our Design IP segment.
v3.25.4
Summary of Significant Accounting Policies and Basis of Presentation
 3 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies and Basis of Presentation Summary of Significant Accounting Policies and Basis of Presentation
We have prepared the accompanying condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, we have condensed or omitted certain information and footnote disclosures we normally include in our annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (U.S. GAAP). The condensed consolidated financial statements are unaudited but, in management’s opinion, we have made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary for a fair presentation of our quarterly results. Our interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in our Annual Report on Form 10-K for the fiscal year ended October 31, 2025 as filed with the SEC on December 22, 2025 (our Annual Report).
Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and could have a material impact on our operating results and financial position.
Principles of Consolidation. The condensed consolidated financial statements include our accounts and the accounts of our wholly and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Year and Fiscal Quarter End. Our fiscal year end is October 31 and our fiscal quarters end on January 31, April 30, and July 31 of each year.
Acquisition of Ansys. On July 17, 2025 (the Acquisition Date), we completed the acquisition of ANSYS, Inc. (Ansys), a provider of broad engineering simulation and analysis software and services for $199.91 in cash and 0.3399 of a share of our common stock in exchange for each ordinary share of Ansys for a total consideration of $34.9 billion.
We accounted for the acquisition of Ansys by applying the acquisition method of accounting for business combinations. See Note 4. Business Combination and Note 10. Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Consolidated Financial Statements in our Annual Report for additional information.
Significant Accounting Policies. There have been no material changes to our significant accounting policies included in our Annual Report.
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. The ASU is effective for our annual reports beginning in fiscal 2026 with early adoption permitted. We are currently evaluating the impact of this ASU on our consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income-Expense Disaggregation (Subtopic 220-40): Disaggregation of Income Statement Expenses. The ASU requires the disclosure of additional information related to certain costs and expenses, including amounts of inventory purchases, employee compensation, and depreciation and amortization included in each income statement line item. The ASU also requires disclosure of the total amount of selling expenses and our definition of selling expenses. The ASU will be effective for our annual reports beginning in fiscal 2028, and interim period reports beginning in fiscal 2029 either on a prospective or retrospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The ASU allows companies to apply a practical expedient when estimating credit losses on current accounts receivable and contract assets. The ASU will be effective for us beginning in fiscal 2027 and will be applied on a prospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the accounting for internal-use software costs and clarifies the criteria for capitalization. The ASU will be effective for us beginning in fiscal 2029, either on a prospective, retrospective, or a modified basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270) Narrow-Scope Improvements. The ASU is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. The ASU will be effective for us beginning in fiscal 2029, either on a prospective or retrospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements. The ASU addresses suggestions received from stakeholders regarding the Accounting Standards Codification and makes other incremental improvements to U.S. GAAP. The update represents changes to the Codification that clarify, correct errors in or make other improvements to a variety of topics that are intended to make it easier to understand and apply. ASU 2025-12 is effective for fiscal years beginning after December 15, 2026 and interim periods within those fiscal years. Entities are required to apply the amendments to ASC 260 retrospectively. All other amendments may be applied prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
v3.25.4
Acquisition of Ansys
 3 Months Ended
Jan. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Acquisition of Ansys Acquisition of Ansys
On July 17, 2025, we completed the acquisition of Ansys (the Ansys Merger) for approximately $34.9 billion, consisting of cash of $17.6 billion (the Cash Consideration), Synopsys Common Stock with a fair value of $17.1 billion, and the balance related to the assumption of certain outstanding Ansys equity awards and the settlement of pre-existing relationships. We acquired Ansys to combine Synopsys’ semiconductor electronic design automation expertise with Ansys’ S&A capabilities to address the growing demand for integrated design and simulation tools across various industries.
We funded the Cash Consideration in the Ansys Merger through a combination of cash on hand, the net proceeds from the issuance of the Senior Notes, and the borrowings under the Term Loan Agreement, each as defined and discussed in Note 10. Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Condensed Consolidated Financial Statements.
We allocated the purchase price to tangible and identified intangible assets acquired and liabilities assumed based on their preliminary estimated fair values, which were determined using generally accepted valuation techniques based on estimates and assumptions made by management at the time of acquisition. These estimates and assumptions are believed to be reasonable, but they are inherently uncertain and may be subject to material change as additional information becomes available during the respective measurement period, which will not exceed 12 months from applicable acquisition date. The primary areas that are preliminary relate to the fair values of goodwill, intangible assets, certain tangible assets and liabilities, and income taxes.
Transaction Costs
Transaction costs for acquisitions, primarily related to the Ansys Merger, were $10.5 million and $56.8 million during the three months ended January 31, 2026 and 2025, respectively. These costs mainly consisted of professional fees, administrative costs for closed and pending acquisitions, as well as the Bridge Commitment financing costs, and were expensed as incurred in our condensed consolidated statements of income.
Supplemental Pro Forma Information (Unaudited)
The following unaudited pro forma financial information presents combined results of operations for the period presented, as if Ansys had been acquired as of the beginning of fiscal year 2024.
Three Months Ended 
 January 31,
2025
(in thousands)
Pro forma total revenue
$2,217,683 
Pro forma net income
$56,366 
This information is provided for informational purposes only and is not necessarily indicative of our consolidated results of operations of the combined business had the acquisition actually occurred at the beginning of fiscal year 2024, or of the results of our future operations of the combined business.
v3.25.4
Revenue
 3 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Revenue
Disaggregated Revenue
The following table shows the percentage of revenue by product groups:
Three Months Ended 
 January 31,
20262025
EDA45.6 %67.3 %
Design IP16.9 %29.9 %
Ansys36.8 %— %
Other0.7 %2.8 %
Total100.0 %100.0 %
Contract Balances
The timing of revenue recognition may differ from the timing of invoicing customers, resulting in receivables, contract assets, or contract liabilities (deferred revenue) in our condensed consolidated balance sheets. For specific software, hardware, and IP agreements with payment plans, we record an unbilled receivable associated with revenue recognized upon transfer of control, as it holds an unconditional right to invoice and receive payment in the future for those transferred products or services. Unbilled receivables are presented as accounts receivable, net, in the condensed consolidated balance sheets.
A contract asset is recorded when revenue is recognized before we have the unconditional right to invoice or retain performance risk concerning that performance obligation. These contract assets transition to receivables when the rights become unconditional, generally upon the completion of a milestone. The contract assets listed below are included in prepaid and other current assets and other long-term assets in the condensed consolidated balance sheets.
Contract balances are as follows:
As of
January 31, 2026October 31, 2025
 (in thousands)
Contract assets, net$1,141,522 $1,222,029 
Unbilled receivables$43,124 $45,528 
Deferred revenue$2,880,009 $2,628,518 
Long-term contract assets were $365.9 million and $336.4 million as of January 31, 2026 and October 31, 2025, respectively.
During the three months ended January 31, 2026, we recognized revenue of $1.1 billion that was included in the deferred revenue balance as of October 31, 2025, including previously unfulfilled contracts that have expired and are no longer subject to an implied promise to provide future services.
Contracted but unsatisfied or partially unsatisfied performance obligations (backlog) were approximately $11.3 billion as of January 31, 2026, which includes $1.9 billion in non-cancellable Flexible Spending Account (FSA) commitments from customers where actual product selection and quantities of specific products or services are to be determined by customers at a later date. We have elected to exclude future sales-based royalty payments from the remaining performance obligations. Approximately 47% of the backlog as of January 31, 2026, excluding non-cancellable FSA, is expected to be recognized as revenue over the next 12 months, with the remainder to be recognized thereafter. The majority of the remaining backlog is expected to be recognized in the following three years.
During the three months ended January 31, 2026 and 2025, we recognized $33.8 million and $25.0 million from performance obligations satisfied from sales-based royalties earned during the periods.
Costs of Obtaining a Contract with Customer
Capitalized commission costs, net of accumulated amortization, as of January 31, 2026 were $115.7 million, of which $27.7 million are included in prepaid and other current assets, and $88.0 million in other long-term assets in our condensed consolidated balance sheets. Amortization of these assets were $19.3 million and $12.5 million
during the three months ended January 31, 2026 and 2025, respectively, and are included in sales and marketing expense in our condensed consolidated statements of income.
v3.25.4
Goodwill and Intangible Assets
 3 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Goodwill and Intangible Assets Goodwill and Intangible Assets
Goodwill
The changes in the carrying amount of goodwill during the three months ended January 31, 2026 are as follows:
 (in thousands)
Balance at October 31, 2025
$26,899,215 
Adjustments(39,616)
Effect of foreign currency translation21,290 
Balance at January 31, 2026
$26,880,889 
Intangible Assets
Intangible assets as of January 31, 2026 consist of the following:
Gross Carrying AmountAccumulated
Amortization
Net Carrying Amount
 (in thousands)
Core/developed technology$7,236,330 $1,040,891 $6,195,439 
Customer relationships5,398,388 553,408 4,844,980 
Contract rights intangible596,819 275,391 321,428 
Trademarks and trade names962,325 34,643 927,682 
Total$14,193,862 $1,904,333 $12,289,529 
Intangible assets as of October 31, 2025 consist of the following:
Gross Carrying AmountAccumulated
Amortization
Net Carrying Amount
 (in thousands)
Core/developed technology$7,309,753 $929,901 $6,379,852 
Customer relationships5,415,558 428,377 4,987,181 
Contract rights intangible614,358 239,808 374,550 
Trademarks and trade names962,925 24,917 938,008 
Total$14,302,594 $1,623,003 $12,679,591 
Amortization expense related to intangible assets consists of the following:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Core/developed technology$193,523 $8,189 
Customer relationships145,667 3,996 
Contract rights intangible54,719 407 
Trademarks and trade names10,326 4 
Total$404,235 $12,596 
The following table presents the estimated future amortization of acquired intangible assets as of January 31, 2026:
Fiscal year(in thousands)
Remainder of fiscal 2026$1,211,259 
20271,547,378 
20281,385,619 
20291,382,920 
20301,376,990 
2031 and thereafter5,385,363 
Total$12,289,529 
v3.25.4
Balance Sheet Components
 3 Months Ended
Jan. 31, 2026
Balance Sheet Related Disclosures [Abstract]  
Balance Sheet Components Balance Sheet Components
As of
January 31, 2026October 31, 2025
(in thousands)
Accounts payable and accrued liabilities:
Payroll and related benefits$685,566 $822,575 
Interest payable
170,480 49,826 
Accounts payable113,263 164,766 
Accrued income taxes111,560 94,664 
Other accrued liabilities223,819 194,380 
Total$1,304,688 $1,326,211 
Other long-term liabilities:
Deferred tax liability
$954,115 $1,001,070 
Deferred compensation plan liabilities464,876 447,232 
Other194,060 200,997 
Total$1,613,051 $1,649,299 
Assets Held For Sale
On January 14, 2026, we entered into a definitive agreement for the sale of our Processor IP Solutions (Processor IP) business to GlobalFoundries Inc. as part of our reallocation of resources to the highest growth opportunities in our Design IP segment.
The Processor IP business is part of the Design IP segment and we have determined that we met the criteria to classify the assets and liabilities of this business as held for sale. The divestiture does not represent a strategic shift in operations that would have a major effect on our business and is also not material to our business and therefore does not meet the criteria to be classified as discontinued operations.
The sale is expected to be completed in the second half of calendar year 2026, subject to the satisfaction of customary closing conditions, including the receipt of required regulatory approvals.
The following table presents the major classes of assets and liabilities classified as held for sale as of January 31, 2026:
(in thousands)
Assets:
Prepaid and other assets
$6,154 
Property and equipment, net2,082 
Operating lease right-of-use assets, net1,870 
Goodwill38,046 
Total current assets held for sale$48,152 
Liabilities:
Accounts payable and accrued liabilities$1,384 
Operating lease liabilities1,850 
Deferred revenue20,391 
Total current liabilities held for sale$23,625 
v3.25.4
Financial Assets and Liabilities
 3 Months Ended
Jan. 31, 2026
Financial Assets And Liabilities [Abstract]  
Financial Assets and Liabilities Financial Assets and Liabilities
Cash Equivalents and Short-term Investments
As of January 31, 2026, the balances of our cash equivalents and short-term investments are as follows:
Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses Less Than 12 Continuous Months		Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value(1)
 (in thousands)
Cash equivalents:
Money market funds$40,825 $— $— $— $40,825 
U.S. Treasury, agency & T-bills2,280 — — — 2,280 
Total:$43,105 $— $— $— $43,105 
Short-term investments:
U.S. Treasury, agency & T-bills$5,014 $20 $— $— $5,034 
Municipal bonds22,903 79 (2)— 22,980 
Corporate debt securities45,538 179 (1)— 45,716 
Other180 — — —180 
Total:$73,635 $278 $(3)$— $73,910 
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
The contractual maturities of our available-for-sale debt securities as of January 31, 2026 are as follows:
Amortized CostFair Value
(in thousands)
1 year or less
$29,693 $29,784 
1-5 years43,942 44,126 
Total$73,635 $73,910 
As of October 31, 2025, the balances of our cash equivalents and short-term investments are as follows:
Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses Less Than 12 Continuous Months		Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value(1)
 (in thousands)
Cash equivalents:
Money market funds$52,978 $— $— $— $52,978 
Total:$52,978 $— $— $— $52,978 
Short-term investments:
U.S. Treasury, agency & T-bills$6,661 $19 $— $— $6,680 
Municipal bonds22,004 61 — — 22,065 
Corporate debt securities43,878 139 (18)— 43,999 
Other185 — — — 185 
Total:$72,728 $219 $(18)$— $72,929 
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
Restricted cash. We include amounts generally described as restricted cash in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown in the condensed consolidated statements of cash flows. Restricted cash is primarily associated with deposits for office leases and employee loan programs.
The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the condensed consolidated balance sheets and the condensed consolidated statements of cash flows:
As of
January 31, 2026October 31, 2025
(in thousands)
Cash and cash equivalents$2,129,572 $2,888,030 
Restricted cash included in prepaid and other current assets3,708 4,680 
Restricted cash included in other long-term assets1,034 1,011 
Cash, cash equivalents and restricted cash
$2,134,314 $2,893,721 
Non-marketable equity securities. Our portfolio of non-marketable equity securities consists of strategic investments in privately held companies. There were no impairments of non-marketable equity securities during the three months ended January 31, 2026 and 2025.
Derivatives
We recognize derivative instruments as either assets or liabilities in the condensed consolidated balance sheets at fair value and provide qualitative and quantitative disclosures about such derivatives. We operate internationally and are exposed to potentially adverse movements in foreign currency exchange and interest rates. We enter into hedges in the form of foreign currency forward contracts to reduce our exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies.
The majority of the forward contracts are short-term with maturity of up to 30 months at inception. We do not use foreign currency forward contracts for speculative or trading purposes. We enter into foreign exchange forward contracts with high credit quality financial institutions that are rated "A" or above and to date have not experienced nonperformance by counterparties. In addition, we mitigate credit risk in derivative transactions by permitting net settlement of transactions with the same counterparty and anticipate continued performance by all counterparties to such agreements.
The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the condensed consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and
qualifies for hedge accounting. The cash flow impact upon settlement of the derivative contracts is included in net cash provided by (used in) operating activities in the condensed consolidated statements of cash flows.
Additionally, in order to manage interest rate exposure related to anticipated debt transactions, in the first quarter of fiscal 2025, we entered into treasury rate lock agreements to hedge against unfavorable interest rate changes. The accounting for gains and losses resulting from changes in fair value depends on whether these are designated and qualify for hedge accounting. The assets or liabilities associated with these derivatives are recorded at fair value in other current assets or accrued liabilities in the condensed consolidated balance sheets. The cash flow impact upon settlement of these derivative contracts is included in net cash provided by (used in) operating activities in the condensed consolidated statements of cash flows.
Cash Flow Hedging Activities
Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of up to 30 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to our foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The related gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (loss) (OCI) in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a majority of the hedge balance in OCI to be reclassified to the statements of income after the next 12 months.
We did not record any gains or losses related to discontinuation of foreign exchange forward contracts cash flow hedges during the three months ended January 31, 2026 and 2025.
During the first quarter of fiscal 2025, we entered into 6-month interest rate hedge contracts (the 2025 Rate Lock Agreements) with notional value of $2.0 billion to manage the variability in cash flows due to changes in benchmark interest rate rated to the Senior Notes (as defined in Note 10. Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Condensed Consolidated Financial Statements). These derivatives were designated as cash flow hedges with unrealized gains and losses deferred in OCI. The 2025 Rate Lock Agreements terminated and settled in the second quarter of fiscal 2025, and we recorded the fair value of $121.6 million as a loss within OCI. The unrealized loss of $121.6 million is being amortized to interest expense over the life of the related debt. We expect $7.0 million of the unrealized loss to be amortized to interest expense over the next 12 months. As of January 31, 2026, the unamortized portion of the fair value of the 2025 Rate Lock Agreements was $115.3 million. We had no interest rate hedge contracts outstanding as of January 31, 2026.
During the second quarter of fiscal 2025, we entered into a deferred payment agreement with the counterparty bank to defer the cash settlement of 2025 Rate Lock Agreements over a period of 5.5 years with installments due semi-annually. The implied interest rate is 3.45%. This liability is recognized in our condensed consolidated balance sheets as short-term debt for the portion due within the next 12 months and as long-term debt for the remaining portion. There were no debt covenants applicable to the deferred payment agreement.
Non-designated Hedging Activities
Our foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging our balance sheet exposure is approximately one month.
We also have certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of these forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of our hedging program is to minimize the impact of currency fluctuations on the net income over the fiscal year.
The effects of the non-designated foreign currency derivative instruments in the condensed consolidated statements of income are summarized as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Gains (losses) recorded in other income (expense), net
$(4,297)$(4,421)
The notional amounts in the table below for foreign currency derivative instruments provide one measure of the transaction volume outstanding:
As of
January 31, 2026October 31, 2025
 (in thousands)
Total gross notional amounts$1,734,610 $1,587,863 
Net fair value$(16,088)$(1,234)
Our exposure to the market gains or losses will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The following table represents the condensed consolidated balance sheets location and amount of foreign currency derivative instrument fair values segregated between designated and non-designated hedge instruments:
Fair values of
derivative instruments
designated as hedging
instruments		Fair values of
derivative instruments
not designated as
hedging instruments
 (in thousands)
Balance at January 31, 2026
Other current assets$11,625 $163 
Accrued liabilities$27,754 $122 
Balance at October 31, 2025
Other current assets$8,598 $265 
Accrued liabilities$9,504 $593 
The following table represents the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the condensed consolidated statements of income:
Location of 
gains (losses) recognized in OCI on derivatives		Amount of 
gains (losses) recognized in OCI on
derivatives
(effective portion)		Location of
gains (losses)
reclassified from OCI		Amount of
gains (losses)
reclassified from
OCI
(effective portion)
 (in thousands)
Three months ended 
 January 31, 2026
Foreign exchange contractsRevenue$2,927 Revenue$1,190 
Foreign exchange contractsOperating expenses(14,463)Operating expenses(1,518)
Interest rate contracts
Interest expense
— Interest expenses(1,332)
Total$(11,536)$(1,660)
Three months ended 
 January 31, 2025
Foreign exchange contractsRevenue$513 Revenue$(1,002)
Foreign exchange contractsOperating expenses(16,891)Operating expenses(2,586)
Total$(16,378)$(3,588)
v3.25.4
Fair Value Measurements
 3 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements Fair Value Measurements
ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
Level 2—Observable inputs other than quoted prices for identical instruments in active markets, quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in inactive markets, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Unobservable inputs derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
On a recurring basis, we measure the fair value of certain assets and liabilities, which include cash equivalents, short-term investments, marketable securities, non-qualified deferred compensation plan assets, contingent consideration receivable, and foreign currency derivative contracts.
Our cash equivalents, short-term investments and marketable securities are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
Our non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
Our foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded, and the valuation inputs are based on quoted prices and market observable data of similar instruments.
Our borrowings under our Credit and Term Loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to us for debt with similar terms and maturities. See Note 10. Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Condensed Consolidated Financial Statements for more information on these borrowings.
Our contingent consideration receivable, which was recorded in connection with the Software Integrity Divestiture, was classified within Level 3 because it was estimated using significant inputs that were not observable in the market.
Assets/Liabilities Measured at Fair Value on a Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below as of January 31, 2026:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
 Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$40,825 $40,825 $— $— 
U.S. Treasury, agency & T-bills2,280 — 2,280 — 
Short-term investments:
U.S. Treasury, agency & T-bills5,034 — 5,034 — 
Municipal bonds22,980 — 22,980 — 
Corporate debt securities45,716 — 45,716 — 
Other180 — 180 — 
Prepaid and other current assets:
Foreign currency derivative contracts11,788 — 11,788 — 
Contingent consideration receivable22,202 — — 22,202 
Other long-term assets:
Deferred compensation plan assets464,876 464,876 — — 
Marketable equity securities
865 865 — — 
Total assets$616,746 $506,566 $87,978 $22,202 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$27,876 $— $27,876 $— 
Other long-term liabilities:
Deferred compensation plan liabilities464,876 464,876 — — 
Total liabilities$492,752 $464,876 $27,876 $— 
Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2025:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$52,978 $52,978 $— $— 
Short-term investments:
U.S. Treasury, agency & T-bills6,680 — 6,680 — 
Municipal bonds22,065 — 22,065 — 
Corporate debt securities43,999 — 43,999 — 
Other185 — 185 — 
Prepaid and other current assets:
Foreign currency derivative contracts8,863 — 8,863 — 
Contingent consideration receivable22,202 — — 22,202 
Other long-term assets:
Deferred compensation plan assets447,232 447,232 — — 
Marketable equity securities
785 785 — — 
Total assets$604,989 $500,995 $81,792 $22,202 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$10,097 $— $10,097 $— 
Other long-term liabilities:
Deferred compensation plan liabilities447,232 447,232 — — 
Total liabilities$457,329 $447,232 $10,097 $— 
Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis
Non-Marketable Equity Securities
Non-marketable equity securities are classified within Level 3 as they are valued using a combination of observable transaction price and unobservable inputs or data in an inactive market due to the absence of market price and inherent lack of liquidity.
v3.25.4
Restructuring Charges
 3 Months Ended
Jan. 31, 2026
Restructuring and Related Activities [Abstract]  
Restructuring Charges Restructuring Charges
In the fourth quarter of fiscal 2025, we initiated a restructuring plan for involuntary employee terminations as part of a business reorganization (the 2026 Plan). Total charges under the 2026 Plan are expected to be in the range of $300.0 million and $350.0 million, and consist primarily of severance costs and other one-time termination benefits. The 2026 Plan is anticipated to be completed by the end of fiscal 2027, with majority of the workforce reduction in fiscal 2026.
During the first quarter of fiscal 2026, we recorded restructuring charges of $118.3 million, and made payments of $86.1 million under the 2026 Plan. As of January 31, 2026, the outstanding restructuring related liabilities were $32.2 million and recorded in accounts payable and accrued liabilities in the condensed consolidated balance sheets.
v3.25.4
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities
 3 Months Ended
Jan. 31, 2026
Debt Disclosure [Abstract]  
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities
The following table summarizes our borrowings as of January 31, 2026:
Effective Interest Rate
Amount
(in thousands)
Fixed-rate 4.550% Senior Notes due on April 1, 2027
4.840 %$1,000,000 
Fixed-rate 4.650% Senior Notes due on April 1, 2028
4.850 %1,000,000 
Fixed-rate 4.850% Senior Notes due on April 1, 2030
4.980 %2,000,000 
Fixed-rate 5.000% Senior Notes due on April 1, 2032
5.150 %1,500,000 
Fixed-rate 5.150% Senior Notes due on April 1, 2035
5.270 %2,400,000 
Fixed-rate 5.700% Senior Notes due on April 1, 2055
5.800 %2,100,000 
Total 10,000,000 
Unamortized discount and issuance costs
(78,336)
Total Senior Notes
9,921,664 
Deferred payment on settlement of interest rate treasury lock
110,585 
Other borrowings
11,961 
Total
$10,044,210 
Reported as:
Short-term debt
$22,117 
Long-term debt10,022,093 
Total$10,044,210 
Senior Notes:
On March 17, 2025, we issued $10.0 billion in aggregate principal amount of senior, unsecured and unsubordinated long-term notes, which mature on various dates from April 1, 2027 to April 1, 2055 (collectively, the Senior Notes). Our total proceeds were approximately $9.9 billion, net of original issuance discount of $17.0 million and total issuance costs of $70.2 million. Interest on the Senior Notes is payable semi-annually on April 1 and October 1 of each year, beginning on October 1, 2025. The discount and issuance costs on our Senior Notes are amortized to interest expense over the terms of the respective notes using the effective interest method. The effective rates for the Senior Notes include the interest on the notes, the accretion of the discount and the amortization of issuance costs.
The Senior Notes were issued under an indenture, dated as of March 17, 2025 (the Base Indenture), as supplemented by the first supplemental indenture, dated as of March 17, 2025 (the Supplemental Indenture and, together with the Base Indenture, the Indenture), each between Synopsys and U.S. Bank Trust Company, National Association, as trustee.
The net proceeds of the Senior Notes were used to fund a portion of the Cash Consideration in the Ansys Merger and pay related transaction fees and expenses.
The Indenture contains provisions for early redemption of the Senior Notes and also contains covenants limiting Synopsys’ ability to create certain liens and enter into certain sale and leaseback transactions. These covenants are subject to important limitations and exceptions as set forth in the Indenture.
Based on the trading prices of the Senior Notes, the fair value of our Senior Notes was $10.1 billion as of January 31, 2026. While the Senior Notes are recorded at cost, the fair value of long-term debt was determined based on observable market prices in less active markets and categorized as Level 2 for purposes of the fair value measurement hierarchy.
As of January 31, 2026, we were in compliance with all of our covenants under the Indenture.
During the first quarter of fiscal 2025, we entered into 6-month interest rate hedge contracts with an aggregate notional amount of $2.0 billion to manage the variability in cash flows due to changes in benchmark interest rates related to the Senior Notes. These interest rate hedge contracts were terminated and settled during the second quarter of fiscal 2025, and we entered into a deferred payment agreement with the counterparty bank to defer the cash settlement. See Note 7. Financial Assets and Liabilities of the Notes to Condensed Consolidated Financial Statements for more information on these cash flow hedging activities.
Bridge Commitment:
On January 15, 2024, we entered into the Bridge Commitment Letter with certain financial institutions that committed to provide, subject to the satisfaction of customary closing conditions, the bridge commitment (the Bridge Commitment) for the purpose of financing a portion of the aggregate Cash Consideration in the Ansys Merger and paying related fees and expenses in connection with the Ansys Merger and the other transactions contemplated by the Merger Agreement.
On October 3, 2024, we reduced the Bridge Commitment by $1.1 billion to $10.6 billion following the closing of the Software Integrity Divestiture. On March 17, 2025, we further reduced the Bridge Commitment by $9.9 billion following the issuance of the Senior Notes. On the Acquisition Date, we terminated the approximately $690.0 million in remaining Bridge Commitment, reducing the Bridge Commitment to $0.
Term Loan:
On February 13, 2024, we entered into a term loan facility credit agreement (the Term Loan Agreement) in connection with the financing of the Ansys Merger. On July 17, 2025, we borrowed the full $4.3 billion available under the Term Loan Agreement to fund a portion of the Cash Consideration in the Ansys Merger and to pay transaction fees, premiums and expenses related to the Ansys Merger.
The Term Loan Agreement provides for two tranches of senior unsecured term loans: a $1.45 billion tranche (Tranche 1) that matures on July 17, 2027 and a $2.85 billion tranche (Tranche 2) that matures on July 17, 2028. On October 17, 2025, we made an early repayment of $850.0 million on the Tranche 1 Term Loan. During the first quarter of fiscal 2026, we paid off the remaining $3.5 billion, and the Term Loans were terminated upon repayment.
Under the Term Loan Agreement, borrowings bear interest on the principal amount outstanding at a floating rate based on, at Synopsys’ election, (i) the Adjusted Term SOFR Rate (as defined in the Term Loan Agreement) plus an applicable margin based on the credit ratings of Synopsys ranging from 0.875% to 1.375% (in the case of Tranche 1) or 1.000% to 1.500% (in the case of Tranche 2) or (ii) the ABR (as defined in the Term Loan Agreement) plus an applicable margin based on the credit ratings of Synopsys ranging from 0.000% to 0.375% (in the case of Tranche 1) or 0.000% to 0.500% (in the case of Tranche 2).
The Term Loan Agreement contains a financial covenant requiring that Synopsys maintain a maximum consolidated leverage ratio, as well as certain other non-financial covenants. As of January 31, 2026, the Term Loans were fully paid off and terminated.
Revolving Credit Facilities:
On February 13, 2024, we entered into a Sixth Amendment Agreement (the Sixth Amendment), which amended and restated our previous revolving credit agreement, dated as of December 14, 2022 (as amended and restated, the Revolving Credit Agreement).
The Revolving Credit Agreement provides an unsecured $850.0 million committed multicurrency revolving credit facility and an unsecured uncommitted incremental revolving loan facility of up to $150.0 million. The maturity date of the revolving credit facility is December 14, 2027, which may be extended at our option.
Under the Sixth Amendment, certain amendments became effective on February 13, 2024 and certain additional amendments became effective on the Acquisition Date. The Sixth Amendment amended the financial covenant to allow netting of the cash proceeds of certain debt incurred to finance the Ansys Merger as well as certain other modifications set forth therein. The Sixth Amendment, among other things, also amended: (i) the applicable margin used to determine the interest that accrues on loans and the facility fee payable under the revolving credit facility to be based on our credit ratings, (ii) the financial covenant thresholds under the financial covenant in the Revolving Credit Agreement requiring us to maintain a maximum consolidated leverage ratio and (iii) certain conditions to borrowing, other non-financial covenants and events of default.
The Revolving Credit Agreement contains a financial covenant requiring us to maintain a maximum consolidated leverage ratio, as well as other non-financial covenants. As of January 31, 2026, we were in compliance with the financial covenant as well as the other covenants.
Interest under the Revolving Credit Agreement accrues on dollar-denominated loans at a floating rate based on, at Synopsys’ election, (i) the Adjusted Term SOFR Rate (as defined in the Revolving Credit Agreement) plus an applicable margin based on our credit ratings ranging from 0.795% to 1.200% or (ii) the ABR (as defined in the Revolving Credit Agreement) plus an applicable margin based on our credit ratings ranging from 0.000% to 0.200%. In addition to the interest on any outstanding loans, Synopsys is also required to pay a facility fee on the entire
portion of the revolving credit facility ranging from 0.080% to 0.175% based on the credit ratings of Synopsys on the daily amount of the revolving commitment.
There was no outstanding balance under the Revolving Credit Agreement as of January 31, 2026 and October 31, 2025.
Other Borrowings:
In July 2018, we entered into a 12-year 220.0 million Renminbi (approximately $33.0 million) credit agreement with a lender in China to support our facilities expansion. Borrowings bear interest at a floating rate based on the 5-year Loan Prime Rate plus 0.74%. As of January 31, 2026, we had $12.0 million outstanding balance under the agreement.
The carrying amount of the short-term and long-term debt approximates the estimated fair value.
The future principal payments of debt as of January 31, 2026 are as follows:
Principal Payments
Fiscal year(in thousands)
Remainder of fiscal 2026$23,446 
20271,024,775 
20281,024,775 
202924,775 
20302,024,775 
2031 and thereafter6,000,000 
Total$10,122,546 
v3.25.4
Leases
 3 Months Ended
Jan. 31, 2026
Leases [Abstract]  
Leases Leases
We have operating lease arrangements for office space, data center, equipment and other corporate assets. These leases have various expiration dates through December 31, 2042, some of which include options to extend the leases for up to 15 years. We consider the lease renewal options in determining the lease term and include associated potential option payments in lease payments when it is reasonably certain that the renewal options will be exercised.
The components of our lease expense during the period presented are as follows:
Three Months Ended January 31,
20262025
(in thousands)
Operating lease expense (1)
$37,206 $25,052 
Variable lease expense (2)
10,517 6,760 
Total lease expense$47,723 $31,812 
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
(2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
Supplemental cash flow information during the period presented is as follows:
Three Months Ended January 31,
20262025
(in thousands)
Cash paid for amounts included in the measurement of operating lease liabilities$34,010 $24,925 
ROU assets obtained in exchange for operating lease liabilities$49,323 $8,848 
Lease term and discount rate information related to our operating leases as of the end of the period presented are as follows:
As of
January 31, 2026October 31, 2025
Weighted-average remaining lease term (in years)6.706.88
Weighted-average discount rate3.34 %3.40 %
The following table represents the maturities of our future lease payments due under operating leases as of January 31, 2026:
Lease Payments
Fiscal year(in thousands)
Remainder of fiscal 2026$117,512 
2027160,939 
2028148,556 
2029139,066 
2030109,836 
2031 and thereafter251,209 
Total future minimum lease payments
927,118 
Less: Imputed interest102,771 
Total lease liabilities
$824,347 
In addition, the sublease income from facilities leased by us, due to us as of January 31, 2026 are as follows:
Lease Receipts
Fiscal year(in thousands)
Remainder of fiscal 2026$14,162 
202719,689 
202820,280 
202920,888 
203017,867 
2031 and thereafter— 
Total$92,886 
v3.25.4
Accumulated Other Comprehensive Income (Loss)
 3 Months Ended
Jan. 31, 2026
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Accumulated Other Comprehensive Income (Loss) Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, are as follows:
As of
January 31, 2026October 31, 2025
 (in thousands)
Cumulative currency translation adjustments$(98,924)$(137,457)
Unrealized gains (losses) on derivative instruments, net of taxes(105,034)(95,158)
Unrealized gains (losses) on available-for-sale securities, net of taxes275 201 
Total$(203,683)$(232,414)
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Reclassifications:
Gains (losses) on cash flow hedges, net of taxes
Revenues$1,190 $(1,002)
Operating expenses(1,518)(2,586)
Interest expense
(1,332)— 
Total$(1,660)$(3,588)
Amounts reclassified during the three months ended January 31, 2026 and 2025 primarily consisted of gains (losses) from our cash flow hedging activities. See Note 7. Financial Assets and Liabilities of the Notes to Condensed Consolidated Financial Statements.
v3.25.4
Stock Repurchase Program
 3 Months Ended
Jan. 31, 2026
Stock Repurchase Program [Abstract]  
Stock Repurchase Program Stock Repurchase Program
In fiscal 2022, our Board of Directors approved a stock repurchase program (the Program) with authorization to purchase up to $1.5 billion of our common stock. As of January 31, 2026, $194.3 million remained available for future repurchases under the Program. In February 2026, the Board approved a replenishment of the Program with authorization to purchase up to $2.0 billion.
The reissuance of treasury stock for employee stock-based compensation purposes are as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Reissuance of treasury stock633 506 
v3.25.4
Stock-Based Compensation
 3 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation Stock-Based Compensation
The compensation cost recognized in the condensed consolidated statements of income for our stock compensation arrangements is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Cost of products$19,973 $20,477 
Cost of maintenance and service13,140 8,991 
Research and development expense123,215 102,696 
Sales and marketing expense60,567 34,950 
General and administrative expense41,829 19,349 
Stock-based compensation expense before taxes
258,724 186,463 
Income tax benefit(40,749)(30,655)
Stock-based compensation expense after taxes$217,975 $155,808 
During the three months ended January 31, 2026 and 2025, we recognized stock-based compensation expense relating to RSUs granted to senior executives with certain market, performance and service conditions (market-based RSUs). The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods are as follows:
 Three Months Ended 
 January 31,
 20262025
Expected life (in years)
2.87
2.79
Risk-free interest rate
3.48%
4.39%
Volatility
44.90%
34.72%
Weighted average grant date fair value per share
$537.83
$464.17
As of January 31, 2026, we had $1.3 billion of total unrecognized stock-based compensation expense relating to options, RSUs and restricted stock awards, which is expected to be recognized over a weighted-average period of 1.8 years. As of January 31, 2026, we had $53.3 million of unrecognized stock-based compensation expense relating to our Employee Stock Purchase Plan, which is expected to be recognized over a period of approximately 2.0 years.
The intrinsic values of equity awards exercised during the periods are as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Intrinsic value of awards exercised$10,362 $20,359 
v3.25.4
Net Income Per Share
 3 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Net Income Per Share Net Income Per Share
We compute basic net income per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted net income per share reflects the dilution from potential common shares outstanding such as stock options and unvested RSUs and awards during the period using the treasury stock method.
The table below reconciles the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
 Three Months Ended 
 January 31,
 20262025
 (in thousands, except per share amounts)
Numerator:
Net income attributed to Synopsys$64,958 $295,683 
Denominator:
Weighted average common shares for basic net income per share189,593 154,408 
Dilutive effect of common share equivalents from equity-based compensation1,169 1,781 
Weighted average common shares for diluted net income per share190,762 156,189 
Net income per share attributed to Synopsys:
Basic
$0.34 $1.91 
Diluted
$0.34 $1.89 
Anti-dilutive employee stock-based awards excluded984 352 
Private Placement
In December 2025, we entered into a securities purchase agreement with NVIDIA Corporation, pursuant to which we sold an aggregate of approximately 4.8 million shares of our common stock in a private placement at a price of $414.79 per share for net proceeds of $2.0 billion.
v3.25.4
Segment Disclosure
 3 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Segment Disclosure Segment Disclosure
Segment reporting is based upon the “management approach,” i.e., how management organizes our operating segments for which separate financial information is (1) available and (2) evaluated regularly by the CODM in deciding how to allocate resources and in assessing performance. Our CODM is our CEO.
We have two reportable segments: (1) Design Automation, which includes our advanced silicon design, verification products and services, Ansys products, system integration products and services, digital, custom and field programmable gate array (FPGA) IC design software, verification software and hardware products, manufacturing software products and other; and (2) Design IP, which includes our logic libraries, embedded memories, wired interface IP, memory interface IP, security IP, and embedded processors.
The financial information provided to and used by the CODM to assist in making operational decisions, allocating resources, and assessing performance includes consolidated financial information as well as revenue, adjusted operating income, and adjusted operating margin information for the Design Automation and Design IP segments, accompanied by disaggregated information relating to revenue by geographic region.
Information by reportable segment is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Total Segments:
Revenue$2,408,798 $1,455,315 
Cost of revenue and operating expenses
1,395,146 924,098 
Adjusted operating income1,013,652 531,217 
Adjusted operating margin42 %37 %
Design Automation:
Revenue$2,001,818 $1,020,216 
Cost of revenue and operating expenses
1,054,286 615,546 
Adjusted operating income947,532 404,670 
Adjusted operating margin47 %40 %
Design IP:
Revenue$406,980 $435,099 
Cost of revenue and operating expenses
340,860 308,552 
Adjusted operating income66,120 126,547 
Adjusted operating margin16 %29 %
Certain operating expenses are not allocated to the segments and are managed at a consolidated level. The unallocated expenses managed at a consolidated level, including amortization of acquired intangible assets, stock-based compensation, changes in the fair value of deferred compensation plan, restructuring charges, and acquisition/divestiture related items, are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Total segment adjusted operating income$1,013,652 $531,217 
Reconciling items:
Amortization of acquired intangible assets
(404,235)(12,596)
Stock-based compensation expense(258,724)(186,463)
Deferred compensation plan(13,773)(19,638)
Restructuring charges(118,282)— 
Acquisition/divestiture related items
(15,592)(60,681)
Total operating income$203,046 $251,839 
The CODM does not use total assets by segment to evaluate segment performance or allocate resources. As a result, total assets by segment are not disclosed.
In allocating revenue to particular geographic areas, the CODM considers where individual “seats” or licenses to our products are located. Revenue is defined as revenue from external customers. Revenue related to operations in the United States and other geographic areas are: 
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Revenue:
United States$1,096,085 $610,710 
Europe467,033 153,671 
China211,083 173,948 
Korea246,616 250,385 
Other387,981 266,601 
Consolidated$2,408,798 $1,455,315 
Geographic revenue data for multi-regional, multi-product transactions reflect internal allocations and are therefore subject to certain assumptions and to our allocation methodology.
v3.25.4
Other Income (Expense), Net
 3 Months Ended
Jan. 31, 2026
Other Income and Expenses [Abstract]  
Other Income (Expense), Net Other Income (Expense), Net
The following table presents the components of other income (expense), net:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Interest income$17,433 $35,721 
Gains on assets related to deferred compensation plan
13,773 19,638 
Foreign currency exchange gains (losses)(5,828)63 
Other, net13,344 (5,005)
Total$38,722 $50,417 
v3.25.4
Income Taxes
 3 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Effective Tax Rate
We estimate our annual effective tax rate at the end of each fiscal quarter. The effective tax rate reflects our estimations of annual pre-tax income, the geographic mix of pre-tax income, interpretations of applicable tax laws and the potential outcomes of audits.
The following table presents the provision for income taxes and the effective tax rates:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Income before income taxes$79,053 $291,117 
Provision (benefit) for income taxes$14,337 $(6,294)
Effective tax rate18.1 %(2.2)%
Our effective tax rate increased in the three months ended January 31, 2026, as compared to the same period in fiscal 2025, primarily due to the reduced benefit from stock-based compensation and foreign-derived intangible income deduction. The capital loss on the sale of our ownership in OpenLight was included in the first quarter of 2025.
Our effective tax rate for the three months ended January 31, 2026, is lower than the statutory federal corporate tax rate of 21% primarily due to U.S. federal research tax credits, foreign-derived intangible income deduction, and U.S. foreign tax credits, partially offset by the effect of non-deductible stock-based compensation.
The timing of the resolution of income tax examinations, and the amounts and timing of various tax payments that are part of the settlement process, are highly uncertain. Variations in such amounts and/or timing could cause large fluctuations in the balance sheet classification of current and non-current assets and liabilities. During the next 12 months, it is reasonably possible that certain audits and ongoing tax litigation will be resolved, or that the statute of limitations on certain state and foreign income and withholding taxes will expire, or both. Given the uncertainty as to ultimate settlement terms, the timing of payment and the impact of such settlements on other uncertain tax positions, we estimate a potential decrease in underlying unrecognized tax benefits to be between $0 and $28.0 million.
Non-U.S. Examinations
One of our Korean subsidiaries, Ansys Korea, is currently involved in various stages of Tax Tribunal and Korea's High Court appeals regarding Korea's National Tax Service assessments of withholding taxes against Ansys Korea for calendar tax years 2017 to 2023. In connection with this matter, we have recorded the net impact of the unrecognized tax benefit and offsetting foreign tax credit.
We are under examinations by tax authorities in certain jurisdictions. No material assessments have been proposed in connection with these examinations.
Legislative Developments
On July 4, 2025, President Donald J. Trump signed H.R. 1, the One Big Beautiful Bill Act (OBBB) into law. The legislation includes corporate income tax changes, including the restoration of immediate expensing for domestic research and experimental expenditures effective beginning in our fiscal 2026, resulting in a decrease to our current cash tax liabilities. Immediate expensing of research and development expenditures also results in a corresponding increase to our effective tax rate due to decreasing the foreign-derived intangible income deduction. The most significant effects begin in our fiscal 2026, with certain provisions extending into fiscal 2027.
Effective in fiscal 2024, we are subject to the new 15% corporate alternative minimum tax (CAMT) enacted as part of the Inflation Reduction Act of 2022 (IR Act). We do not expect to be subject to CAMT in fiscal 2026, due to our regular tax liability exceeding CAMT. The details of the computation will be subject to final regulations issued by the U.S. Department of the Treasury. We will monitor regulatory developments and will continue to evaluate the impact, if any, of the CAMT.
On June 27, 2024, California enacted SB-167, which suspends the use of California net operating loss and limits the use of California research tax credits to $5 million for our fiscal 2025-2027. On June 29, 2024, California
enacted SB-175, which provides a refund mechanism effective beginning in our fiscal 2025 for the incremental tax that was paid as a result of SB-167.
The Organisation for Economic Co-operation and Development (the OECD) has model rules for a global minimum tax framework, which is a two-pillar solution to address tax challenges arising from digitalization of the economy. This two-pillar solution includes the Pillar Two Model Rules (Pillar 2), which define global minimum tax rules and imposes a 15% minimum tax rate. Various countries have started to enact new laws related to Pillar 2, including certain new laws effective beginning in fiscal 2025. As of January 31, 2026, the impact of Pillar 2 is not material.
v3.25.4
Contingencies
 3 Months Ended
Jan. 31, 2026
Commitments and Contingencies Disclosure [Abstract]  
Contingencies Contingencies
Legal Proceedings
We are subject to routine legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. For more detail on currently pending legal proceedings, see Part II, Item 1, Legal Proceedings. The ultimate outcome of any litigation is often uncertain and unfavorable outcomes could have a negative impact on our results of operations and financial condition. We regularly review the status of each significant matter and assess its potential financial exposure. If the potential loss from any claim or legal proceeding is considered probable and the amount is estimable, we accrue a liability for the estimated loss. Legal proceedings are inherently uncertain and as circumstances change, it is possible that the amount of any accrued liability may increase, decrease or be eliminated.
We have determined that no disclosure of estimated loss is required for a claim against us because: (1) there is not a reasonable possibility that a loss exceeding amounts already recognized (if any) may be incurred with respect to such claim; (2) a reasonably possible loss or range of loss cannot be estimated; or (3) such estimate is immaterial.
Tax Matters
We undergo examination from time to time by U.S. and foreign authorities for non-income based taxes, such as sales, use and value-added taxes, and are currently under examination by tax authorities in certain jurisdictions. If the potential loss from such examinations is considered probable and the amount or the range of loss could be estimated, we would accrue a liability for the estimated expense.
In addition to the foregoing, we are, from time to time, party to various other claims and legal proceedings in the ordinary course of our business, including with tax and other governmental authorities. For a description of certain of these other matters, see Note 18. Income Taxes of the Notes to Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q.
v3.25.4
Insider Trading Arrangements
 3 Months Ended
Jan. 31, 2026
shares
Trading Arrangements, by Individual  
Material Terms of Trading Arrangement
None of our directors or officers informed us of the adoption, modification or termination of a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" (as those terms are defined in Item 408(c) of Regulation S-K) during the quarterly period covered by this report, except as described in the table below:
Name and TitleAction
Date Adopted
Character of Trading Arrangement(1)
Aggregate Number of Common Stock to be Purchased or Sold Pursuant to Trading Arrangement
Expiration Date(2)
Shelagh Glaser
Adoption 1/13/2026Rule 10b5-1 Trading Arrangement
Up to 11,085 shares to be sold
12/31/2026
Chief Financial Officer
Rick Mahoney
Termination(3)
9/13/2024Rule 10b5-1 Trading Arrangement
(4)
1/16/2026
Former Chief Revenue Officer
(1)Except as indicated by footnote, each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” is intended to satisfy the affirmative defense of Rule 10b5-1(c), as amended (the Rule).
(2)Except as indicated by footnote, each trading arrangement permitted or permits transactions through and including the earlier to occur of (a) the completion of all purchases or sales or (b) the date listed in the table. Each trading arrangement marked as a “Rule 10b5-1 Trading Arrangement” only permitted or only permits transactions upon expiration of the applicable mandatory cooling-off period under the Rule.
(3)Terminated as of November 11, 2025.
(4)For additional details about the material terms of this arrangement, refer to the description under the heading "Insider Adoption or Termination of Trading Arrangements" contained in Part II, Item 9B, Other Information of our Annual Report on Form 10-K for the year ended October 31, 2024, which is incorporated herein by reference.
Non-Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Terminated false
Shelagh Glaser [Member]  
Trading Arrangements, by Individual  
Name Shelagh Glaser
Title Chief Financial Officer
Rule 10b5-1 Arrangement Adopted true
Adoption Date 1/13/2026
Expiration Date 12/31/2026
Arrangement Duration 352 days
Aggregate Available 11,085
Rick Mahoney [Member]  
Trading Arrangements, by Individual  
Name Rick Mahoney
Title Former Chief Revenue Officer
Rule 10b5-1 Arrangement Terminated true
Termination Date 1/16/2026
v3.25.4
Summary of Significant Accounting Policies and Basis of Presentation (Policies)
 3 Months Ended
Jan. 31, 2026
Accounting Policies [Abstract]  
Use of Estimates
Use of Estimates. To prepare financial statements in conformity with U.S. GAAP, management must make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and could have a material impact on our operating results and financial position.
Principles of Consolidation
Principles of Consolidation. The condensed consolidated financial statements include our accounts and the accounts of our wholly and majority-owned subsidiaries. All intercompany accounts and transactions have been eliminated in consolidation.
Fiscal Year and Fiscal Quarter End
Fiscal Year and Fiscal Quarter End. Our fiscal year end is October 31 and our fiscal quarters end on January 31, April 30, and July 31 of each year.
Acquisition of Ansys
Acquisition of Ansys. On July 17, 2025 (the Acquisition Date), we completed the acquisition of ANSYS, Inc. (Ansys), a provider of broad engineering simulation and analysis software and services for $199.91 in cash and 0.3399 of a share of our common stock in exchange for each ordinary share of Ansys for a total consideration of $34.9 billion.
We accounted for the acquisition of Ansys by applying the acquisition method of accounting for business combinations.
Recent Accounting Pronouncements Not Yet Adopted
Recent Accounting Pronouncements Not Yet Adopted
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which enhances the transparency and decision usefulness of income tax disclosures primarily through changes to the rate reconciliation and income taxes paid information. The ASU is effective for our annual reports beginning in fiscal 2026 with early adoption permitted. We are currently evaluating the impact of this ASU on our consolidated financial statements and related disclosures.
In November 2024, the FASB issued ASU 2024-03, Income Statement – Reporting Comprehensive Income-Expense Disaggregation (Subtopic 220-40): Disaggregation of Income Statement Expenses. The ASU requires the disclosure of additional information related to certain costs and expenses, including amounts of inventory purchases, employee compensation, and depreciation and amortization included in each income statement line item. The ASU also requires disclosure of the total amount of selling expenses and our definition of selling expenses. The ASU will be effective for our annual reports beginning in fiscal 2028, and interim period reports beginning in fiscal 2029 either on a prospective or retrospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The ASU allows companies to apply a practical expedient when estimating credit losses on current accounts receivable and contract assets. The ASU will be effective for us beginning in fiscal 2027 and will be applied on a prospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In September 2025, the FASB issued ASU 2025-06, Intangibles-Goodwill and Other-Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software, which modernizes the accounting for internal-use software costs and clarifies the criteria for capitalization. The ASU will be effective for us beginning in fiscal 2029, either on a prospective, retrospective, or a modified basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU 2025-11, Interim Reporting (Topic 270) Narrow-Scope Improvements. The ASU is intended to improve the navigability of the guidance in ASC 270, Interim Reporting, and clarify when it applies. Under the amendments, an entity is subject to ASC 270 if it provides interim financial statements and notes in accordance with GAAP. ASU 2025-11 also addresses the form and content of such financial statements, interim disclosures requirements, and establishes a principle under which an entity must disclose events since the end of the last annual reporting period that have a material impact on the entity. The ASU will be effective for us beginning in fiscal 2029, either on a prospective or retrospective basis. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU 2025-12, Codification Improvements. The ASU addresses suggestions received from stakeholders regarding the Accounting Standards Codification and makes other incremental improvements to U.S. GAAP. The update represents changes to the Codification that clarify, correct errors in or make other improvements to a variety of topics that are intended to make it easier to understand and apply. ASU 2025-12 is effective for fiscal years beginning after December 15, 2026 and interim periods within those fiscal years. Entities are required to apply the amendments to ASC 260 retrospectively. All other amendments may be applied prospectively or retrospectively. Early adoption is permitted. We are currently evaluating the impact of adopting this ASU on our consolidated financial statements and related disclosures.
Restricted cash
Restricted cash. We include amounts generally described as restricted cash in cash and cash equivalents when reconciling beginning-of-period and end-of-period total amounts shown in the condensed consolidated statements of cash flows. Restricted cash is primarily associated with deposits for office leases and employee loan programs.
Fair Value Measurements
ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements. The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
Level 2—Observable inputs other than quoted prices for identical instruments in active markets, quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in inactive markets, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
Level 3—Unobservable inputs derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
On a recurring basis, we measure the fair value of certain assets and liabilities, which include cash equivalents, short-term investments, marketable securities, non-qualified deferred compensation plan assets, contingent consideration receivable, and foreign currency derivative contracts.
Our cash equivalents, short-term investments and marketable securities are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
Our non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
Our foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded, and the valuation inputs are based on quoted prices and market observable data of similar instruments.
Our borrowings under our Credit and Term Loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to us for debt with similar terms and maturities. See Note 10. Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities of the Notes to Condensed Consolidated Financial Statements for more information on these borrowings.
Our contingent consideration receivable, which was recorded in connection with the Software Integrity Divestiture, was classified within Level 3 because it was estimated using significant inputs that were not observable in the market.
v3.25.4
Acquisition of Ansys (Tables)
 3 Months Ended
Jan. 31, 2026
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Schedule of Unaudited Pro Forma Information
The following unaudited pro forma financial information presents combined results of operations for the period presented, as if Ansys had been acquired as of the beginning of fiscal year 2024.
Three Months Ended 
 January 31,
2025
(in thousands)
Pro forma total revenue
$2,217,683 
Pro forma net income
$56,366 
v3.25.4
Revenue (Tables)
 3 Months Ended
Jan. 31, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
The following table shows the percentage of revenue by product groups:
Three Months Ended 
 January 31,
20262025
EDA45.6 %67.3 %
Design IP16.9 %29.9 %
Ansys36.8 %— %
Other0.7 %2.8 %
Total100.0 %100.0 %
Schedule of Contract Assets and Liabilities
Contract balances are as follows:
As of
January 31, 2026October 31, 2025
 (in thousands)
Contract assets, net$1,141,522 $1,222,029 
Unbilled receivables$43,124 $45,528 
Deferred revenue$2,880,009 $2,628,518 
v3.25.4
Goodwill and Intangible Assets (Tables)
 3 Months Ended
Jan. 31, 2026
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of Goodwill
The changes in the carrying amount of goodwill during the three months ended January 31, 2026 are as follows:
 (in thousands)
Balance at October 31, 2025
$26,899,215 
Adjustments(39,616)
Effect of foreign currency translation21,290 
Balance at January 31, 2026
$26,880,889 
Schedule of Intangible Assets
Intangible assets as of January 31, 2026 consist of the following:
Gross Carrying AmountAccumulated
Amortization
Net Carrying Amount
 (in thousands)
Core/developed technology$7,236,330 $1,040,891 $6,195,439 
Customer relationships5,398,388 553,408 4,844,980 
Contract rights intangible596,819 275,391 321,428 
Trademarks and trade names962,325 34,643 927,682 
Total$14,193,862 $1,904,333 $12,289,529 
Intangible assets as of October 31, 2025 consist of the following:
Gross Carrying AmountAccumulated
Amortization
Net Carrying Amount
 (in thousands)
Core/developed technology$7,309,753 $929,901 $6,379,852 
Customer relationships5,415,558 428,377 4,987,181 
Contract rights intangible614,358 239,808 374,550 
Trademarks and trade names962,925 24,917 938,008 
Total$14,302,594 $1,623,003 $12,679,591 
Schedule of Amortization Expense Related to Intangible Assets
Amortization expense related to intangible assets consists of the following:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Core/developed technology$193,523 $8,189 
Customer relationships145,667 3,996 
Contract rights intangible54,719 407 
Trademarks and trade names10,326 4 
Total$404,235 $12,596 
Schedule of Estimated Future Amortization of Acquired Intangible Assets
The following table presents the estimated future amortization of acquired intangible assets as of January 31, 2026:
Fiscal year(in thousands)
Remainder of fiscal 2026$1,211,259 
20271,547,378 
20281,385,619 
20291,382,920 
20301,376,990 
2031 and thereafter5,385,363 
Total$12,289,529 
v3.25.4
Balance Sheet Components (Tables)
 3 Months Ended
Jan. 31, 2026
Balance Sheet Related Disclosures [Abstract]  
Schedule of Balance Sheets Components
As of
January 31, 2026October 31, 2025
(in thousands)
Accounts payable and accrued liabilities:
Payroll and related benefits$685,566 $822,575 
Interest payable
170,480 49,826 
Accounts payable113,263 164,766 
Accrued income taxes111,560 94,664 
Other accrued liabilities223,819 194,380 
Total$1,304,688 $1,326,211 
Other long-term liabilities:
Deferred tax liability
$954,115 $1,001,070 
Deferred compensation plan liabilities464,876 447,232 
Other194,060 200,997 
Total$1,613,051 $1,649,299 
Schedule of Assets and Liabilities Classified as Held for Sale
The following table presents the major classes of assets and liabilities classified as held for sale as of January 31, 2026:
(in thousands)
Assets:
Prepaid and other assets
$6,154 
Property and equipment, net2,082 
Operating lease right-of-use assets, net1,870 
Goodwill38,046 
Total current assets held for sale$48,152 
Liabilities:
Accounts payable and accrued liabilities$1,384 
Operating lease liabilities1,850 
Deferred revenue20,391 
Total current liabilities held for sale$23,625 
v3.25.4
Financial Assets and Liabilities (Tables)
 3 Months Ended
Jan. 31, 2026
Financial Assets And Liabilities [Abstract]  
Schedule of Cash Equivalents and Short-Term Investments
As of January 31, 2026, the balances of our cash equivalents and short-term investments are as follows:
Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses Less Than 12 Continuous Months		Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value(1)
 (in thousands)
Cash equivalents:
Money market funds$40,825 $— $— $— $40,825 
U.S. Treasury, agency & T-bills2,280 — — — 2,280 
Total:$43,105 $— $— $— $43,105 
Short-term investments:
U.S. Treasury, agency & T-bills$5,014 $20 $— $— $5,034 
Municipal bonds22,903 79 (2)— 22,980 
Corporate debt securities45,538 179 (1)— 45,716 
Other180 — — —180 
Total:$73,635 $278 $(3)$— $73,910 
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
The contractual maturities of our available-for-sale debt securities as of January 31, 2026 are as follows:
Amortized CostFair Value
(in thousands)
1 year or less
$29,693 $29,784 
1-5 years43,942 44,126 
Total$73,635 $73,910 
As of October 31, 2025, the balances of our cash equivalents and short-term investments are as follows:
Amortized CostGross
Unrealized
Gains		Gross
Unrealized
Losses Less Than 12 Continuous Months		Gross
Unrealized
Losses 12 Continuous Months or Longer
Estimated
Fair Value(1)
 (in thousands)
Cash equivalents:
Money market funds$52,978 $— $— $— $52,978 
Total:$52,978 $— $— $— $52,978 
Short-term investments:
U.S. Treasury, agency & T-bills$6,661 $19 $— $— $6,680 
Municipal bonds22,004 61 — — 22,065 
Corporate debt securities43,878 139 (18)— 43,999 
Other185 — — — 185 
Total:$72,728 $219 $(18)$— $72,929 
(1)See Note 8. Fair Value Measurements for further discussion on fair values.
Schedule of Cash, Cash Equivalents and Restricted Cash
The following table provides a reconciliation of cash, cash equivalents and restricted cash included in the condensed consolidated balance sheets and the condensed consolidated statements of cash flows:
As of
January 31, 2026October 31, 2025
(in thousands)
Cash and cash equivalents$2,129,572 $2,888,030 
Restricted cash included in prepaid and other current assets3,708 4,680 
Restricted cash included in other long-term assets1,034 1,011 
Cash, cash equivalents and restricted cash
$2,134,314 $2,893,721 
Schedule of Effects on Changes in Fair Values of Non-Designated Forward Contracts
The effects of the non-designated foreign currency derivative instruments in the condensed consolidated statements of income are summarized as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Gains (losses) recorded in other income (expense), net
$(4,297)$(4,421)
Schedule of Notional Amounts of Foreign Currency Derivative Instruments
The notional amounts in the table below for foreign currency derivative instruments provide one measure of the transaction volume outstanding:
As of
January 31, 2026October 31, 2025
 (in thousands)
Total gross notional amounts$1,734,610 $1,587,863 
Net fair value$(16,088)$(1,234)
Schedule of Fair Values of Foreign Currency Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet
The following table represents the condensed consolidated balance sheets location and amount of foreign currency derivative instrument fair values segregated between designated and non-designated hedge instruments:
Fair values of
derivative instruments
designated as hedging
instruments		Fair values of
derivative instruments
not designated as
hedging instruments
 (in thousands)
Balance at January 31, 2026
Other current assets$11,625 $163 
Accrued liabilities$27,754 $122 
Balance at October 31, 2025
Other current assets$8,598 $265 
Accrued liabilities$9,504 $593 
Schedule of Location of the Amounts of Gains and Losses on Derivative Instrument Fair Values for Designated Hedging Instruments, Net of Tax
The following table represents the location of the amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax in the condensed consolidated statements of income:
Location of 
gains (losses) recognized in OCI on derivatives		Amount of 
gains (losses) recognized in OCI on
derivatives
(effective portion)		Location of
gains (losses)
reclassified from OCI		Amount of
gains (losses)
reclassified from
OCI
(effective portion)
 (in thousands)
Three months ended 
 January 31, 2026
Foreign exchange contractsRevenue$2,927 Revenue$1,190 
Foreign exchange contractsOperating expenses(14,463)Operating expenses(1,518)
Interest rate contracts
Interest expense
— Interest expenses(1,332)
Total$(11,536)$(1,660)
Three months ended 
 January 31, 2025
Foreign exchange contractsRevenue$513 Revenue$(1,002)
Foreign exchange contractsOperating expenses(16,891)Operating expenses(2,586)
Total$(16,378)$(3,588)
v3.25.4
Fair Value Measurements (Tables)
 3 Months Ended
Jan. 31, 2026
Fair Value Disclosures [Abstract]  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis
Assets and liabilities measured at fair value on a recurring basis are summarized below as of January 31, 2026:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable
 Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$40,825 $40,825 $— $— 
U.S. Treasury, agency & T-bills2,280 — 2,280 — 
Short-term investments:
U.S. Treasury, agency & T-bills5,034 — 5,034 — 
Municipal bonds22,980 — 22,980 — 
Corporate debt securities45,716 — 45,716 — 
Other180 — 180 — 
Prepaid and other current assets:
Foreign currency derivative contracts11,788 — 11,788 — 
Contingent consideration receivable22,202 — — 22,202 
Other long-term assets:
Deferred compensation plan assets464,876 464,876 — — 
Marketable equity securities
865 865 — — 
Total assets$616,746 $506,566 $87,978 $22,202 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$27,876 $— $27,876 $— 
Other long-term liabilities:
Deferred compensation plan liabilities464,876 464,876 — — 
Total liabilities$492,752 $464,876 $27,876 $— 
Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2025:
  Fair Value Measurement Using
DescriptionTotalQuoted Prices in 
Active Markets
for Identical Assets
(Level 1)		Significant Other
Observable Inputs
(Level 2)		Significant
Unobservable 
Inputs
(Level 3)
 (in thousands)
Assets
Cash equivalents:
Money market funds$52,978 $52,978 $— $— 
Short-term investments:
U.S. Treasury, agency & T-bills6,680 — 6,680 — 
Municipal bonds22,065 — 22,065 — 
Corporate debt securities43,999 — 43,999 — 
Other185 — 185 — 
Prepaid and other current assets:
Foreign currency derivative contracts8,863 — 8,863 — 
Contingent consideration receivable22,202 — — 22,202 
Other long-term assets:
Deferred compensation plan assets447,232 447,232 — — 
Marketable equity securities
785 785 — — 
Total assets$604,989 $500,995 $81,792 $22,202 
Liabilities
Accounts payable and accrued liabilities:
Foreign currency derivative contracts$10,097 $— $10,097 $— 
Other long-term liabilities:
Deferred compensation plan liabilities447,232 447,232 — — 
Total liabilities$457,329 $447,232 $10,097 $— 
v3.25.4
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities (Tables)
 3 Months Ended
Jan. 31, 2026
Debt Disclosure [Abstract]  
Schedule of Borrowings
The following table summarizes our borrowings as of January 31, 2026:
Effective Interest Rate
Amount
(in thousands)
Fixed-rate 4.550% Senior Notes due on April 1, 2027
4.840 %$1,000,000 
Fixed-rate 4.650% Senior Notes due on April 1, 2028
4.850 %1,000,000 
Fixed-rate 4.850% Senior Notes due on April 1, 2030
4.980 %2,000,000 
Fixed-rate 5.000% Senior Notes due on April 1, 2032
5.150 %1,500,000 
Fixed-rate 5.150% Senior Notes due on April 1, 2035
5.270 %2,400,000 
Fixed-rate 5.700% Senior Notes due on April 1, 2055
5.800 %2,100,000 
Total 10,000,000 
Unamortized discount and issuance costs
(78,336)
Total Senior Notes
9,921,664 
Deferred payment on settlement of interest rate treasury lock
110,585 
Other borrowings
11,961 
Total
$10,044,210 
Reported as:
Short-term debt
$22,117 
Long-term debt10,022,093 
Total$10,044,210 
Schedule of Future Principal Payments of Debt
The future principal payments of debt as of January 31, 2026 are as follows:
Principal Payments
Fiscal year(in thousands)
Remainder of fiscal 2026$23,446 
20271,024,775 
20281,024,775 
202924,775 
20302,024,775 
2031 and thereafter6,000,000 
Total$10,122,546 
v3.25.4
Leases (Tables)
 3 Months Ended
Jan. 31, 2026
Leases [Abstract]  
Schedule of Components of Lease Expense and Supplemental Cash Flow Information
The components of our lease expense during the period presented are as follows:
Three Months Ended January 31,
20262025
(in thousands)
Operating lease expense (1)
$37,206 $25,052 
Variable lease expense (2)
10,517 6,760 
Total lease expense$47,723 $31,812 
(1) Operating lease expense includes immaterial amounts of short-term leases, net of sublease income.
(2) Variable lease expense includes payments to lessors that are not fixed or determinable at lease commencement date. These payments primarily consist of maintenance, property taxes, insurance and variable indexed based payments.
Supplemental cash flow information during the period presented is as follows:
Three Months Ended January 31,
20262025
(in thousands)
Cash paid for amounts included in the measurement of operating lease liabilities$34,010 $24,925 
ROU assets obtained in exchange for operating lease liabilities$49,323 $8,848 
Schedule of Lease Term and Discount Rate Information
Lease term and discount rate information related to our operating leases as of the end of the period presented are as follows:
As of
January 31, 2026October 31, 2025
Weighted-average remaining lease term (in years)6.706.88
Weighted-average discount rate3.34 %3.40 %
Schedule of Maturities of Future Lease Payments Under Operating Leases, and Sublease Income
The following table represents the maturities of our future lease payments due under operating leases as of January 31, 2026:
Lease Payments
Fiscal year(in thousands)
Remainder of fiscal 2026$117,512 
2027160,939 
2028148,556 
2029139,066 
2030109,836 
2031 and thereafter251,209 
Total future minimum lease payments
927,118 
Less: Imputed interest102,771 
Total lease liabilities
$824,347 
In addition, the sublease income from facilities leased by us, due to us as of January 31, 2026 are as follows:
Lease Receipts
Fiscal year(in thousands)
Remainder of fiscal 2026$14,162 
202719,689 
202820,280 
202920,888 
203017,867 
2031 and thereafter— 
Total$92,886 
v3.25.4
Accumulated Other Comprehensive Income (Loss) (Tables)
 3 Months Ended
Jan. 31, 2026
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]  
Schedule of Components of Accumulated Other Comprehensive Income (Loss)
The components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, are as follows:
As of
January 31, 2026October 31, 2025
 (in thousands)
Cumulative currency translation adjustments$(98,924)$(137,457)
Unrealized gains (losses) on derivative instruments, net of taxes(105,034)(95,158)
Unrealized gains (losses) on available-for-sale securities, net of taxes275 201 
Total$(203,683)$(232,414)
Schedule of Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income
The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Reclassifications:
Gains (losses) on cash flow hedges, net of taxes
Revenues$1,190 $(1,002)
Operating expenses(1,518)(2,586)
Interest expense
(1,332)— 
Total$(1,660)$(3,588)
v3.25.4
Stock Repurchase Program (Tables)
 3 Months Ended
Jan. 31, 2026
Stock Repurchase Program [Abstract]  
Schedule of Stock Repurchase And Reissuance Activities
The reissuance of treasury stock for employee stock-based compensation purposes are as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Reissuance of treasury stock633 506 
v3.25.4
Stock-Based Compensation (Tables)
 3 Months Ended
Jan. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock Compensation Arrangements
The compensation cost recognized in the condensed consolidated statements of income for our stock compensation arrangements is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Cost of products$19,973 $20,477 
Cost of maintenance and service13,140 8,991 
Research and development expense123,215 102,696 
Sales and marketing expense60,567 34,950 
General and administrative expense41,829 19,349 
Stock-based compensation expense before taxes
258,724 186,463 
Income tax benefit(40,749)(30,655)
Stock-based compensation expense after taxes$217,975 $155,808 
Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions The grant date fair value of the market-based RSUs and the assumptions used in the Monte Carlo simulation model to determine the grant date fair value during the periods are as follows:
 Three Months Ended 
 January 31,
 20262025
Expected life (in years)
2.87
2.79
Risk-free interest rate
3.48%
4.39%
Volatility
44.90%
34.72%
Weighted average grant date fair value per share
$537.83
$464.17
Schedule of Intrinsic Value of Equity Awards Exercised
The intrinsic values of equity awards exercised during the periods are as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Intrinsic value of awards exercised$10,362 $20,359 
v3.25.4
Net Income Per Share (Tables)
 3 Months Ended
Jan. 31, 2026
Earnings Per Share [Abstract]  
Schedule of Reconciliation of Weighted-Average Common Shares Used to Calculate Net Income Per Share
The table below reconciles the weighted average common shares used to calculate basic net income per share with the weighted average common shares used to calculate diluted net income per share:
 Three Months Ended 
 January 31,
 20262025
 (in thousands, except per share amounts)
Numerator:
Net income attributed to Synopsys$64,958 $295,683 
Denominator:
Weighted average common shares for basic net income per share189,593 154,408 
Dilutive effect of common share equivalents from equity-based compensation1,169 1,781 
Weighted average common shares for diluted net income per share190,762 156,189 
Net income per share attributed to Synopsys:
Basic
$0.34 $1.91 
Diluted
$0.34 $1.89 
Anti-dilutive employee stock-based awards excluded984 352 
v3.25.4
Segment Disclosure (Tables)
 3 Months Ended
Jan. 31, 2026
Segment Reporting [Abstract]  
Schedule of Segment Reporting Information
Information by reportable segment is as follows:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Total Segments:
Revenue$2,408,798 $1,455,315 
Cost of revenue and operating expenses
1,395,146 924,098 
Adjusted operating income1,013,652 531,217 
Adjusted operating margin42 %37 %
Design Automation:
Revenue$2,001,818 $1,020,216 
Cost of revenue and operating expenses
1,054,286 615,546 
Adjusted operating income947,532 404,670 
Adjusted operating margin47 %40 %
Design IP:
Revenue$406,980 $435,099 
Cost of revenue and operating expenses
340,860 308,552 
Adjusted operating income66,120 126,547 
Adjusted operating margin16 %29 %
Schedule of Reconciliation of Operating Income from Segments to Consolidation The unallocated expenses managed at a consolidated level, including amortization of acquired intangible assets, stock-based compensation, changes in the fair value of deferred compensation plan, restructuring charges, and acquisition/divestiture related items, are presented in the table below to provide a reconciliation of the total adjusted operating income from segments to our consolidated operating income:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Total segment adjusted operating income$1,013,652 $531,217 
Reconciling items:
Amortization of acquired intangible assets
(404,235)(12,596)
Stock-based compensation expense(258,724)(186,463)
Deferred compensation plan(13,773)(19,638)
Restructuring charges(118,282)— 
Acquisition/divestiture related items
(15,592)(60,681)
Total operating income$203,046 $251,839 
Schedule of Revenues Related to Operations by Geographic Areas Revenue related to operations in the United States and other geographic areas are: 
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Revenue:
United States$1,096,085 $610,710 
Europe467,033 153,671 
China211,083 173,948 
Korea246,616 250,385 
Other387,981 266,601 
Consolidated$2,408,798 $1,455,315 
v3.25.4
Other Income (Expense), Net (Tables)
 3 Months Ended
Jan. 31, 2026
Other Income and Expenses [Abstract]  
Schedule of Components of Interest and Other Income (Expense), Net
The following table presents the components of other income (expense), net:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Interest income$17,433 $35,721 
Gains on assets related to deferred compensation plan
13,773 19,638 
Foreign currency exchange gains (losses)(5,828)63 
Other, net13,344 (5,005)
Total$38,722 $50,417 
v3.25.4
Income Taxes (Tables)
 3 Months Ended
Jan. 31, 2026
Income Tax Disclosure [Abstract]  
Schedule of Provision for Incomes Taxes and Effective Tax Rates
The following table presents the provision for income taxes and the effective tax rates:
 Three Months Ended 
 January 31,
 20262025
 (in thousands)
Income before income taxes$79,053 $291,117 
Provision (benefit) for income taxes$14,337 $(6,294)
Effective tax rate18.1 %(2.2)%
v3.25.4
Summary of Significant Accounting Policies and Basis of Presentation (Details) - Ansys, Inc
$ / shares in Units, $ in Billions
Jul. 17, 2025
USD ($)
$ / shares
Business Combination [Line Items]  
Business acquisition, share price (in USD per share) | $ / shares $ 199.91
Business acquisition, exchange ratio 0.3399
Total purchase consideration | $ $ 34.9
v3.25.4
Acquisition of Ansys - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Jul. 17, 2025
Jan. 31, 2026
Jan. 31, 2025
Business Combination [Line Items]      
Transaction costs   $ 10.5 $ 56.8
Ansys, Inc      
Business Combination [Line Items]      
Total purchase consideration $ 34,900.0    
Payment to acquire business 17,600.0    
Fair value of common stock issued $ 17,100.0    
v3.25.4
Acquisition of Ansys - Schedule of Unaudited Pro Forma Information (Details)
$ in Thousands
 3 Months Ended
Jan. 31, 2025
USD ($)
Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation [Abstract]  
Pro forma total revenue $ 2,217,683
Pro forma net income $ 56,366
v3.25.4
Revenue - Schedule of Disaggregation of Revenue (Details) - Product Concentration Risk - Revenues
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Disaggregation of Revenue [Line Items]    
Revenue percentage by product group 100.00% 100.00%
EDA    
Disaggregation of Revenue [Line Items]    
Revenue percentage by product group 45.60% 67.30%
Design IP    
Disaggregation of Revenue [Line Items]    
Revenue percentage by product group 16.90% 29.90%
Ansys    
Disaggregation of Revenue [Line Items]    
Revenue percentage by product group 36.80% 0.00%
Other    
Disaggregation of Revenue [Line Items]    
Revenue percentage by product group 0.70% 2.80%
v3.25.4
Revenue - Schedule of Contract Assets and Liabilities (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Revenue from Contract with Customer [Abstract]    
Contract assets, net $ 1,141,522 $ 1,222,029
Unbilled receivables 43,124 45,528
Deferred revenue $ 2,880,009 $ 2,628,518
v3.25.4
Revenue - Additional Information (Details) - USD ($)
$ in Millions
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Oct. 31, 2025
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Long term contract assets $ 365.9   $ 336.4
Contract with customer, liability, revenue recognized 1,100.0    
Revenue, remaining performance obligation, amount 11,300.0    
Revenue, remaining performance obligation, non-cancellable, amount 1,900.0    
Capitalized contract cost, net 115.7    
Capitalized contract cost, current 27.7    
Capitalized contract cost, noncurrent 88.0    
Amortization of capitalized costs to obtain revenue contracts 19.3 $ 12.5  
Sales Based Royalties      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Contract with customer, liability, revenue recognized $ 33.8 $ 25.0  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-02-01      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, remaining performance obligation, percentage 47.00%    
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2027-02-01      
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]      
Revenue, remaining performance obligation, expected timing of satisfaction, period 3 years    
v3.25.4
Goodwill and Intangible Assets - Schedule of Goodwill (Details)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
USD ($)
Goodwill [Roll Forward]  
Beginning balance $ 26,899,215
Adjustments (39,616)
Effect of foreign currency translation 21,290
Ending balance $ 26,880,889
v3.25.4
Goodwill and Intangible Assets - Schedule of Intangible Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 14,193,862 $ 14,302,594
Accumulated Amortization 1,904,333 1,623,003
Total 12,289,529 12,679,591
Core/developed technology    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 7,236,330 7,309,753
Accumulated Amortization 1,040,891 929,901
Total 6,195,439 6,379,852
Customer relationships    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 5,398,388 5,415,558
Accumulated Amortization 553,408 428,377
Total 4,844,980 4,987,181
Contract rights intangible    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 596,819 614,358
Accumulated Amortization 275,391 239,808
Total 321,428 374,550
Trademarks and trade names    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 962,325 962,925
Accumulated Amortization 34,643 24,917
Total $ 927,682 $ 938,008
v3.25.4
Goodwill and Intangible Assets - Schedule of Amortization Expense Related to Intangible Assets (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Finite Lived Intangible Assets Amortization Expense [Line Items]    
Amortization of intangible expense $ 404,235 $ 12,596
Core/developed technology    
Finite Lived Intangible Assets Amortization Expense [Line Items]    
Amortization of intangible expense 193,523 8,189
Customer relationships    
Finite Lived Intangible Assets Amortization Expense [Line Items]    
Amortization of intangible expense 145,667 3,996
Contract rights intangible    
Finite Lived Intangible Assets Amortization Expense [Line Items]    
Amortization of intangible expense 54,719 407
Trademarks and trade names    
Finite Lived Intangible Assets Amortization Expense [Line Items]    
Amortization of intangible expense $ 10,326 $ 4
v3.25.4
Goodwill and Intangible Assets - Schedule of Estimated Future Amortization of Intangible Assets (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
Remainder of fiscal 2026 $ 1,211,259  
2027 1,547,378  
2028 1,385,619  
2029 1,382,920  
2030 1,376,990  
2031 and thereafter 5,385,363  
Total $ 12,289,529 $ 12,679,591
v3.25.4
Balance Sheet Components - Schedule of Balance Sheets Components (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Accounts payable and accrued liabilities:    
Payroll and related benefits $ 685,566 $ 822,575
Interest payable 170,480 49,826
Accounts payable 113,263 164,766
Accrued income taxes 111,560 94,664
Other accrued liabilities 223,819 194,380
Total 1,304,688 1,326,211
Other long-term liabilities:    
Deferred tax liability 954,115 1,001,070
Deferred compensation plan liabilities 464,876 447,232
Other 194,060 200,997
Total $ 1,613,051 $ 1,649,299
v3.25.4
Balance Sheet Components - Schedule of Assets and Liabilities Classified as Held for Sale (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Assets:    
Total current assets held for sale $ 48,152 $ 0
Liabilities:    
Total current liabilities held for sale 23,625 $ 0
Disposal Group, Held-for-Sale, Not Discontinued Operations    
Assets:    
Prepaid and other assets 6,154  
Property and equipment, net 2,082  
Operating lease right-of-use assets, net 1,870  
Goodwill 38,046  
Total current assets held for sale 48,152  
Liabilities:    
Accounts payable and accrued liabilities 1,384  
Operating lease liabilities 1,850  
Deferred revenue 20,391  
Total current liabilities held for sale $ 23,625  
v3.25.4
Financial Assets and Liabilities - Schedule of Cash Equivalents and Short-Term Investments (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Cash Equivalents and Short-term Investments [Line Items]    
Cash equivalents $ 43,105 $ 52,978
Cash equivalents, fair value 43,105 52,978
Amortized Cost 73,635 72,728
Gross Unrealized Gains 278 219
Gross Unrealized Losses Less Than 12 Continuous Months (3) (18)
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated Fair Value 73,910 72,929
U.S. Treasury, agency & T-bills    
Cash Equivalents and Short-term Investments [Line Items]    
Amortized Cost 5,014 6,661
Gross Unrealized Gains 20 19
Gross Unrealized Losses Less Than 12 Continuous Months 0 0
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated Fair Value 5,034 6,680
Municipal bonds    
Cash Equivalents and Short-term Investments [Line Items]    
Amortized Cost 22,903 22,004
Gross Unrealized Gains 79 61
Gross Unrealized Losses Less Than 12 Continuous Months (2) 0
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated Fair Value 22,980 22,065
Corporate debt securities    
Cash Equivalents and Short-term Investments [Line Items]    
Amortized Cost 45,538 43,878
Gross Unrealized Gains 179 139
Gross Unrealized Losses Less Than 12 Continuous Months (1) (18)
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated Fair Value 45,716 43,999
Others    
Cash Equivalents and Short-term Investments [Line Items]    
Amortized Cost 180 185
Gross Unrealized Gains 0 0
Gross Unrealized Losses Less Than 12 Continuous Months 0 0
Gross Unrealized Losses 12 Continuous Months or Longer 0 0
Estimated Fair Value 180 185
Money market funds    
Cash Equivalents and Short-term Investments [Line Items]    
Cash equivalents 40,825 52,978
Cash equivalents, fair value 40,825 $ 52,978
U.S. Treasury, agency & T-bills    
Cash Equivalents and Short-term Investments [Line Items]    
Cash equivalents 2,280  
Cash equivalents, fair value $ 2,280  
v3.25.4
Financial Assets and Liabilities - Schedule of Maturity for Short-Term Available for Sale Securities (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Amortized Cost    
1 year or less $ 29,693  
1-5 years 43,942  
Amortized Cost 73,635 $ 72,728
Fair Value    
1 year or less 29,784  
1-5 years 44,126  
Fair Value $ 73,910 $ 72,929
v3.25.4
Financial Assets and Liabilities - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Jan. 31, 2025
Oct. 31, 2024
Financial Assets And Liabilities [Abstract]        
Cash and cash equivalents $ 2,129,572 $ 2,888,030    
Restricted cash included in prepaid and other current assets 3,708 4,680    
Restricted cash included in other long-term assets 1,034 1,011    
Cash, cash equivalents and restricted cash, beginning of year $ 2,134,314 $ 2,893,721 $ 3,657,780 $ 3,898,729
v3.25.4
Financial Assets and Liabilities - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Apr. 30, 2025
Jan. 31, 2025
Oct. 31, 2025
Oct. 31, 2024
Financial Assets and Liabilities [Line Items]          
Impairment of non-marketable equity securities $ 0   $ 0    
Gains (losses) related to discontinuation of cash flow hedges 0   0    
Total stockholders’ equity $ (30,547,998)   $ (9,304,901) $ (28,327,015) $ (8,993,206)
Foreign exchange contracts          
Financial Assets and Liabilities [Line Items]          
Shipments period using hedges (in months) 1 month        
Derivative maturity period 30 months        
Total gross notional amounts $ 1,734,610     $ 1,587,863  
Foreign exchange contracts | Cash Flow Hedges          
Financial Assets and Liabilities [Line Items]          
Derivative maturity period 30 months        
Derivative, exposure period 3 years        
Period for hedge balance in OCI to be reclassified to statement of operations (in months) 12 months        
Interest rate contracts | Cash Flow Hedges          
Financial Assets and Liabilities [Line Items]          
Derivative maturity period     6 months    
Total gross notional amounts     $ 2,000,000    
Debt instrument, term   5 years 6 months      
Implied interest rate   3.45%      
Interest rate contract settled          
Financial Assets and Liabilities [Line Items]          
Loss recorded in OCI   $ 121,600      
Expected unrealized loss to be amortized to interest expense over the next twelve months $ 7,000        
Interest rate contract settled | Unrealized gains (losses) on derivative instruments, net of taxes          
Financial Assets and Liabilities [Line Items]          
Total stockholders’ equity $ 115,300        
Foreign Exchange Forward, Hedge of Non-Functional Currency | Fair values of derivative instruments not designated as hedging instruments          
Financial Assets and Liabilities [Line Items]          
Forward contracts terms (in months) 1 month        
Foreign Exchange Forward, Hedge of Non-Functional Currency | Fair values of derivative instruments not designated as hedging instruments          
Financial Assets and Liabilities [Line Items]          
Non-designated foreign exchange forward contract remaining maturity 1 year        
v3.25.4
Financial Assets and Liabilities - Schedule of Effects on Changes in Fair Values of Non-Designated Foreign Currency Forward Contracts (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Financial Assets And Liabilities [Abstract]    
Gains (losses) recorded in other income (expense), net $ (4,297) $ (4,421)
v3.25.4
Financial Assets and Liabilities - Schedule of Notional Amounts of Foreign Currency Derivative Instruments (Details) - Foreign exchange contracts - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Derivative Instruments and Hedging Activities Disclosures [Line Items]    
Total gross notional amounts $ 1,734,610 $ 1,587,863
Net fair value $ (16,088) $ (1,234)
v3.25.4
Financial Assets and Liabilities - Schedule of Fair Values of Foreign Currency Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet (Details) - Foreign exchange contracts - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Fair values of derivative instruments designated as hedging instruments | Other current assets    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, assets $ 11,625 $ 8,598
Fair values of derivative instruments designated as hedging instruments | Accrued liabilities    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, liabilities 27,754 9,504
Fair values of derivative instruments not designated as hedging instruments | Other current assets    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, assets 163 265
Fair values of derivative instruments not designated as hedging instruments | Accrued liabilities    
Financial Assets and Liabilities [Line Items]    
Fair values of derivative instruments, liabilities $ 122 $ 593
v3.25.4
Financial Assets and Liabilities - Schedule of Location of the Amounts of Gains and Losses on Derivative Instrument Fair Values for Designated Hedging Instruments, Net of Tax (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Financial Assets and Liabilities [Line Items]    
Amount of  gains (losses) recognized in OCI on derivatives (effective portion) $ (11,536) $ (36,448)
Amount of gains (losses) reclassified from OCI (effective portion) (1,660) (3,588)
Foreign exchange contracts    
Financial Assets and Liabilities [Line Items]    
Amount of  gains (losses) recognized in OCI on derivatives (effective portion)   (16,378)
Amount of gains (losses) reclassified from OCI (effective portion)   (3,588)
Foreign exchange contracts | Revenue    
Financial Assets and Liabilities [Line Items]    
Amount of  gains (losses) recognized in OCI on derivatives (effective portion) 2,927 513
Amount of gains (losses) reclassified from OCI (effective portion) 1,190 (1,002)
Foreign exchange contracts | Operating expenses    
Financial Assets and Liabilities [Line Items]    
Amount of  gains (losses) recognized in OCI on derivatives (effective portion) (14,463) (16,891)
Amount of gains (losses) reclassified from OCI (effective portion) (1,518) $ (2,586)
Interest rate contracts    
Financial Assets and Liabilities [Line Items]    
Amount of  gains (losses) recognized in OCI on derivatives (effective portion) 0  
Amount of gains (losses) reclassified from OCI (effective portion) $ (1,332)  
v3.25.4
Fair Value Measurements (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Assets    
Cash equivalents, fair value $ 43,105 $ 52,978
Short-term investments 73,910 72,929
Liabilities    
Deferred compensation plan liabilities 464,876 447,232
U.S. Treasury, agency & T-bills    
Assets    
Short-term investments 5,034 6,680
Municipal bonds    
Assets    
Short-term investments 22,980 22,065
Corporate debt securities    
Assets    
Short-term investments 45,716 43,999
Others    
Assets    
Short-term investments 180 185
Money market funds    
Assets    
Cash equivalents, fair value 40,825 52,978
U.S. Treasury, agency & T-bills    
Assets    
Cash equivalents, fair value 2,280  
Fair Value, Measurements, Recurring    
Prepaid and other current assets:    
Contingent consideration receivable 22,202 22,202
Other long-term assets:    
Deferred compensation plan assets 464,876 447,232
Marketable equity securities 865 785
Total assets 616,746 604,989
Liabilities    
Deferred compensation plan liabilities 464,876 447,232
Total liabilities 492,752 457,329
Fair Value, Measurements, Recurring | Foreign currency derivative contracts    
Prepaid and other current assets:    
Foreign currency derivative contracts 11,788 8,863
Liabilities    
Accounts payable and accrued liabilities: 27,876 10,097
Fair Value, Measurements, Recurring | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Prepaid and other current assets:    
Contingent consideration receivable 0 0
Other long-term assets:    
Deferred compensation plan assets 464,876 447,232
Marketable equity securities 865 785
Total assets 506,566 500,995
Liabilities    
Deferred compensation plan liabilities 464,876 447,232
Total liabilities 464,876 447,232
Fair Value, Measurements, Recurring | Quoted Prices in  Active Markets for Identical Assets (Level 1) | Foreign currency derivative contracts    
Prepaid and other current assets:    
Foreign currency derivative contracts 0 0
Liabilities    
Accounts payable and accrued liabilities: 0 0
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2)    
Prepaid and other current assets:    
Contingent consideration receivable 0 0
Other long-term assets:    
Deferred compensation plan assets 0 0
Marketable equity securities 0 0
Total assets 87,978 81,792
Liabilities    
Deferred compensation plan liabilities 0 0
Total liabilities 27,876 10,097
Fair Value, Measurements, Recurring | Significant Other Observable Inputs (Level 2) | Foreign currency derivative contracts    
Prepaid and other current assets:    
Foreign currency derivative contracts 11,788 8,863
Liabilities    
Accounts payable and accrued liabilities: 27,876 10,097
Fair Value, Measurements, Recurring | Significant Unobservable  Inputs (Level 3)    
Prepaid and other current assets:    
Contingent consideration receivable 22,202 22,202
Other long-term assets:    
Deferred compensation plan assets 0 0
Marketable equity securities 0 0
Total assets 22,202 22,202
Liabilities    
Deferred compensation plan liabilities 0 0
Total liabilities 0 0
Fair Value, Measurements, Recurring | Significant Unobservable  Inputs (Level 3) | Foreign currency derivative contracts    
Prepaid and other current assets:    
Foreign currency derivative contracts 0 0
Liabilities    
Accounts payable and accrued liabilities: 0 0
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills    
Assets    
Short-term investments 5,034 6,680
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Significant Other Observable Inputs (Level 2)    
Assets    
Short-term investments 5,034 6,680
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Significant Unobservable  Inputs (Level 3)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Municipal bonds    
Assets    
Short-term investments 22,980 22,065
Fair Value, Measurements, Recurring | Municipal bonds | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Municipal bonds | Significant Other Observable Inputs (Level 2)    
Assets    
Short-term investments 22,980 22,065
Fair Value, Measurements, Recurring | Municipal bonds | Significant Unobservable  Inputs (Level 3)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Corporate debt securities    
Assets    
Short-term investments 45,716 43,999
Fair Value, Measurements, Recurring | Corporate debt securities | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Corporate debt securities | Significant Other Observable Inputs (Level 2)    
Assets    
Short-term investments 45,716 43,999
Fair Value, Measurements, Recurring | Corporate debt securities | Significant Unobservable  Inputs (Level 3)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Others    
Assets    
Short-term investments 180 185
Fair Value, Measurements, Recurring | Others | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Others | Significant Other Observable Inputs (Level 2)    
Assets    
Short-term investments 180 185
Fair Value, Measurements, Recurring | Others | Significant Unobservable  Inputs (Level 3)    
Assets    
Short-term investments 0 0
Fair Value, Measurements, Recurring | Money market funds    
Assets    
Cash equivalents, fair value 40,825 52,978
Fair Value, Measurements, Recurring | Money market funds | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Cash equivalents, fair value 40,825 52,978
Fair Value, Measurements, Recurring | Money market funds | Significant Other Observable Inputs (Level 2)    
Assets    
Cash equivalents, fair value 0 0
Fair Value, Measurements, Recurring | Money market funds | Significant Unobservable  Inputs (Level 3)    
Assets    
Cash equivalents, fair value 0 $ 0
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills    
Assets    
Cash equivalents, fair value 2,280  
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Quoted Prices in  Active Markets for Identical Assets (Level 1)    
Assets    
Cash equivalents, fair value 0  
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Significant Other Observable Inputs (Level 2)    
Assets    
Cash equivalents, fair value 2,280  
Fair Value, Measurements, Recurring | U.S. Treasury, agency & T-bills | Significant Unobservable  Inputs (Level 3)    
Assets    
Cash equivalents, fair value $ 0  
v3.25.4
Restructuring Charges (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Restructuring Cost and Reserve [Line Items]    
Restructuring charges $ 118,282 $ 0
Payments for restructuring 86,100  
Restructuring related liabilities $ 32,200  
Minimum    
Restructuring Cost and Reserve [Line Items]    
Restructuring, expected cost   300,000
Maximum    
Restructuring Cost and Reserve [Line Items]    
Restructuring, expected cost   $ 350,000
v3.25.4
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities - Schedule of Borrowings (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Mar. 17, 2025
Debt Instrument [Line Items]      
Total $ 10,122,546    
Deferred payment on settlement of interest rate treasury lock 110,585    
Other borrowings 11,961    
Total 10,044,210    
Short-term debt 22,117 $ 22,117  
Long-term debt 10,022,093 $ 13,462,398  
Senior Notes and Line of Credit      
Debt Instrument [Line Items]      
Total 9,921,664    
Senior Notes      
Debt Instrument [Line Items]      
Total 10,000,000    
Unamortized discount and issuance costs $ (78,336)    
Senior Notes | Fixed-rate 4.550% Senior Notes due on April 1, 2027      
Debt Instrument [Line Items]      
Stated interest rate     4.55%
Effective Interest Rate 4.84%    
Total $ 1,000,000    
Senior Notes | Fixed-rate 4.650% Senior Notes due on April 1, 2028      
Debt Instrument [Line Items]      
Stated interest rate     4.65%
Effective Interest Rate 4.85%    
Total $ 1,000,000    
Senior Notes | Fixed-rate 4.850% Senior Notes due on April 1, 2030      
Debt Instrument [Line Items]      
Stated interest rate     4.85%
Effective Interest Rate 4.98%    
Total $ 2,000,000    
Senior Notes | Fixed-rate 5.000% Senior Notes due on April 1, 2032      
Debt Instrument [Line Items]      
Stated interest rate     5.00%
Effective Interest Rate 5.15%    
Total $ 1,500,000    
Senior Notes | Fixed-rate 5.150% Senior Notes due on April 1, 2035      
Debt Instrument [Line Items]      
Stated interest rate     5.15%
Effective Interest Rate 5.27%    
Total $ 2,400,000    
Senior Notes | Fixed-rate 5.700% Senior Notes due on April 1, 2055      
Debt Instrument [Line Items]      
Stated interest rate     5.70%
Effective Interest Rate 5.80%    
Total $ 2,100,000    
v3.25.4
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities - Additional Information (Details)
¥ in Millions
 1 Months Ended 3 Months Ended
Oct. 17, 2025
USD ($)
Jul. 17, 2025
USD ($)
Mar. 17, 2025
USD ($)
Feb. 13, 2024
USD ($)
Jul. 31, 2018
USD ($)
Jan. 31, 2026
USD ($)
Jan. 31, 2025
USD ($)
Oct. 31, 2025
USD ($)
Oct. 03, 2024
USD ($)
Jul. 31, 2018
CNY (¥)
Debt Instrument [Line Items]                    
Repayments of debt           $ 3,451,310,000 $ 1,289,000      
Interest Rate Contracts | Cash Flow Hedges                    
Debt Instrument [Line Items]                    
Derivative maturity period             6 months      
Total gross notional amounts             $ 2,000,000,000.0      
Senior Notes                    
Debt Instrument [Line Items]                    
Debt instrument, face amount     $ 10,000,000,000.0              
Proceeds from debt, net of issuance costs     9,900,000,000              
Unamortized discount and issuance costs     17,000,000.0              
Debt issuance costs     70,200,000              
Long-term debt, fair value           10,100,000,000        
Line of Credit | Bridge Commitment | Bridge Loan                    
Debt Instrument [Line Items]                    
Decrease in credit facility maximum borrowing capacity   $ 690,000,000.0 $ 9,900,000,000           $ 1,100,000,000  
Maximum borrowing capacity   0             $ 10,600,000,000  
Line of Credit | Term Loan Agreement | Unsecured term loans                    
Debt Instrument [Line Items]                    
Amount borrowed   $ 4,300,000,000                
Repayments of debt           3,500,000,000        
Line of Credit | Term Loan due 2027 (Tranche 1) | Unsecured term loans                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity       $ 1,450,000,000            
Repayments of debt $ 850,000,000.0                  
Line of Credit | Term Loan due 2027 (Tranche 1) | Unsecured term loans | Minimum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       0.875%            
Line of Credit | Term Loan due 2027 (Tranche 1) | Unsecured term loans | Minimum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       0.00%            
Line of Credit | Term Loan due 2027 (Tranche 1) | Unsecured term loans | Maximum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       1.375%            
Line of Credit | Term Loan due 2027 (Tranche 1) | Unsecured term loans | Maximum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       0.375%            
Line of Credit | Term Loan due 2028 (Tranche 2) | Unsecured term loans                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity       $ 2,850,000,000            
Line of Credit | Term Loan due 2028 (Tranche 2) | Unsecured term loans | Minimum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       1.00%            
Line of Credit | Term Loan due 2028 (Tranche 2) | Unsecured term loans | Minimum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       0.00%            
Line of Credit | Term Loan due 2028 (Tranche 2) | Unsecured term loans | Maximum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       1.50%            
Line of Credit | Term Loan due 2028 (Tranche 2) | Unsecured term loans | Maximum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate       0.50%            
Line of Credit | Senior Unsecured Committed Multicurrency Revolving Credit Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity       $ 850,000,000.0            
Line of Credit | Unsecured Uncommitted Incremental Revolving Loan Facility | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity       $ 150,000,000.0            
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility                    
Debt Instrument [Line Items]                    
Amount outstanding           $ 0   $ 0    
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Minimum                    
Debt Instrument [Line Items]                    
Commitment fees percentage           0.08%        
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Minimum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate           0.795%        
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Minimum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate           0.00%        
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Maximum                    
Debt Instrument [Line Items]                    
Commitment fees percentage           0.175%        
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Maximum | SOFR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate           1.20%        
Line of Credit | Revolving Credit Agreement | Revolving Credit Facility | Maximum | ABR                    
Debt Instrument [Line Items]                    
Borrowings, interest rate           0.20%        
Foreign Line of Credit                    
Debt Instrument [Line Items]                    
Maximum borrowing capacity         $ 33,000,000.0         ¥ 220.0
Amount outstanding           $ 12,000,000.0        
Borrowings, interest rate         0.74%          
Debt instrument, term         12 years          
v3.25.4
Senior Notes, Bridge Commitment Letter, Term Loan and Revolving Credit Facilities - Schedule of Future Principal Payments of Debt (Details)
$ in Thousands
Jan. 31, 2026
USD ($)
Debt Disclosure [Abstract]  
Remainder of fiscal 2026 $ 23,446
2027 1,024,775
2028 1,024,775
2029 24,775
2030 2,024,775
2031 and thereafter 6,000,000
Total $ 10,122,546
v3.25.4
Leases - Additional Information (Details)
Jan. 31, 2026
Leases [Abstract]  
Lessee, operating lease, renewal term 15 years
v3.25.4
Leases - Schedule of Components of Lease Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Leases [Abstract]    
Operating lease expense $ 37,206 $ 25,052
Variable lease expense 10,517 6,760
Total lease expense $ 47,723 $ 31,812
v3.25.4
Leases - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Leases [Abstract]    
Cash paid for amounts included in the measurement of operating lease liabilities $ 34,010 $ 24,925
ROU assets obtained in exchange for operating lease liabilities $ 49,323 $ 8,848
v3.25.4
Leases - Schedule of Lease Term and Discount Rate Information (Details)
Jan. 31, 2026
Oct. 31, 2025
Leases [Abstract]    
Weighted-average remaining lease term (in years) 6 years 8 months 12 days 6 years 10 months 17 days
Weighted-average discount rate 3.34% 3.40%
v3.25.4
Leases - Schedule of Future Minimum Payments (Details)
$ in Thousands
Jan. 31, 2026
USD ($)
Leases [Abstract]  
Remainder of fiscal 2026 $ 117,512
2027 160,939
2028 148,556
2029 139,066
2030 109,836
2031 and thereafter 251,209
Total future minimum lease payments 927,118
Less: Imputed interest 102,771
Total lease liabilities $ 824,347
v3.25.4
Leases - Schedule of Sublease Income from Facilities Under Operating Leases (Details)
$ in Thousands
Jan. 31, 2026
USD ($)
Leases [Abstract]  
Remainder of fiscal 2026 $ 14,162
2027 19,689
2028 20,280
2029 20,888
2030 17,867
2031 and thereafter 0
Total $ 92,886
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Schedule of Components of Accumulated Other Comprehensive Income (Loss) (Details) - USD ($)
$ in Thousands
Jan. 31, 2026
Oct. 31, 2025
Jan. 31, 2025
Oct. 31, 2024
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Total $ 30,547,998 $ 28,327,015 $ 9,304,901 $ 8,993,206
Accumulated Other Comprehensive Income (Loss)        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Total (203,683) (232,414) $ (241,919) $ (180,380)
Cumulative currency translation adjustments        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Total (98,924) (137,457)    
Unrealized gains (losses) on derivative instruments, net of taxes        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Total (105,034) (95,158)    
Unrealized gains (losses) on available-for-sale securities, net of taxes        
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]        
Total $ 275 $ 201    
v3.25.4
Accumulated Other Comprehensive Income (Loss) - Schedule of Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Revenue $ 2,408,798 $ 1,455,315
Operating expenses (1,568,370) (933,501)
Interest expense (162,715) (11,139)
Net income attributed to Synopsys 64,958 295,683
Reclassifications: | Unrealized gains (losses) on derivative instruments, net of taxes    
Reclassification Adjustment Balance In Accumulated Other Comprehensive Income [Line Items]    
Revenue 1,190 (1,002)
Operating expenses (1,518) (2,586)
Interest expense (1,332) 0
Net income attributed to Synopsys $ (1,660) $ (3,588)
v3.25.4
Stock Repurchase Program - Additional Information (Details) - USD ($)
$ in Millions
Feb. 25, 2026
Jan. 31, 2026
Oct. 31, 2022
Subsequent Event [Line Items]      
Stock repurchase program authorized amount     $ 1,500.0
Remaining amount available for further repurchases   $ 194.3  
Subsequent Event      
Subsequent Event [Line Items]      
Stock repurchase program authorized amount $ 2,000.0    
v3.25.4
Stock Repurchase Program - Schedule of Reissuance Activities of Treasury Stock (Details) - shares
shares in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Stock Repurchase Program [Abstract]    
Reissuance of treasury stock (in shares) 633 506
v3.25.4
Stock-Based Compensation - Schedule of Stock Compensation Expense (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes $ 258,724 $ 186,463
Income tax benefit (40,749) (30,655)
Stock-based compensation expense after taxes 217,975 155,808
Cost of products    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes 19,973 20,477
Cost of maintenance and service    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes 13,140 8,991
Research and development expense    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes 123,215 102,696
Sales and marketing expense    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes 60,567 34,950
General and administrative expense    
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Stock-based compensation expense before taxes $ 41,829 $ 19,349
v3.25.4
Stock-Based Compensation - Schedule of Share-Based Payment Award, Restricted Stock Units, Valuation Assumptions (Details) - Restricted Stock Units (RSUs), Market-based - $ / shares
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]    
Expected life (in years) 2 years 10 months 13 days 2 years 9 months 14 days
Risk-free interest rate 3.48% 4.39%
Volatility 44.90% 34.72%
Weighted average grant date fair value (in USD per share) $ 537.83 $ 464.17
v3.25.4
Stock-Based Compensation - Additional Information (Details)
$ in Millions
 3 Months Ended
Jan. 31, 2026
USD ($)
Options, Restricted Stock and Restricted Stock Units  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation expense $ 1,300.0
Weighted-average period of recognition for unrecognized stock-based compensation expense 1 year 9 months 18 days
ESPP  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Unrecognized stock-based compensation expense $ 53.3
Weighted-average period of recognition for unrecognized stock-based compensation expense 2 years
v3.25.4
Stock-Based Compensation - Schedule of Intrinsic Value of Equity Awards Exercised (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Stock Compensation [Abstract]    
Intrinsic value of awards exercised $ 10,362 $ 20,359
v3.25.4
Net Income Per Share - Schedule of Reconciliation of Weighted-Average Common Shares Used to Calculate Net Income Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Numerator:    
Net income attributed to Synopsys $ 64,958 $ 295,683
Denominator:    
Weighted average common shares for basic net income per share (in shares) 189,593 154,408
Dilutive effect of common share equivalents from equity-based compensation (in shares) 1,169 1,781
Weighted average common shares for diluted net income per share (in shares) 190,762 156,189
Net income per share attributed to Synopsys:    
Basic (in USD per share) $ 0.34 $ 1.91
Diluted (in USD per share) $ 0.34 $ 1.89
Anti-dilutive employee stock-based awards excluded (in shares) 984 352
v3.25.4
Net Income Per Share - Narrative (Details) - USD ($)
$ / shares in Units, $ in Thousands, shares in Millions
 1 Months Ended 3 Months Ended
Dec. 31, 2025
Jan. 31, 2026
Jan. 31, 2025
Class of Stock [Line Items]      
Common stock issuance for private placement $ 2,000,000 $ 2,000,000 $ 0
Private Placement      
Class of Stock [Line Items]      
Sale of stock, number of shares of common stock issued (in shares) 4.8    
Sale of stock, price per share (in USD per share) $ 414.79    
v3.25.4
Segment Disclosure - Additional information (Details)
 3 Months Ended
Jan. 31, 2026
segment
Segment Reporting [Abstract]  
Number of reportable segments 2
v3.25.4
Segment Disclosure - Schedule of Segment Reporting Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Segment Reporting Information [Line Items]    
Revenue $ 2,408,798 $ 1,455,315
Adjusted operating income 203,046 251,839
Design Automation:    
Segment Reporting Information [Line Items]    
Revenue 2,001,818 1,020,216
Cost of revenue and operating expenses 1,054,286 615,546
Adjusted operating income $ 947,532 $ 404,670
Adjusted operating margin 47.00% 40.00%
Design IP:    
Segment Reporting Information [Line Items]    
Revenue $ 406,980 $ 435,099
Cost of revenue and operating expenses 340,860 308,552
Adjusted operating income $ 66,120 $ 126,547
Adjusted operating margin 16.00% 29.00%
Operating Segments    
Segment Reporting Information [Line Items]    
Revenue $ 2,408,798 $ 1,455,315
Cost of revenue and operating expenses 1,395,146 924,098
Adjusted operating income $ 1,013,652 $ 531,217
Adjusted operating margin 42.00% 37.00%
v3.25.4
Segment Disclosure - Schedule of Reconciliation of Operating Income from Segments to Consolidation (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Segment Reporting Information [Line Items]    
Adjusted operating income $ 203,046 $ 251,839
Amortization of acquired intangible assets (404,235) (12,596)
Stock-based compensation expense (258,724) (186,463)
Deferred compensation plan (13,773) (19,638)
Restructuring charges (118,282) 0
Operating Segments    
Segment Reporting Information [Line Items]    
Adjusted operating income 1,013,652 531,217
Reconciling items: | Continuing Operations    
Segment Reporting Information [Line Items]    
Amortization of acquired intangible assets (404,235) (12,596)
Stock-based compensation expense (258,724) (186,463)
Deferred compensation plan (13,773) (19,638)
Restructuring charges (118,282) 0
Acquisition/divestiture related items $ (15,592) $ (60,681)
v3.25.4
Segment Disclosure - Schedule of Revenues Related to Operations by Geographic Areas (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Schedule of Revenues from External Customers [Line Items]    
Total revenue $ 2,408,798 $ 1,455,315
United States    
Schedule of Revenues from External Customers [Line Items]    
Total revenue 1,096,085 610,710
Europe    
Schedule of Revenues from External Customers [Line Items]    
Total revenue 467,033 153,671
China    
Schedule of Revenues from External Customers [Line Items]    
Total revenue 211,083 173,948
Korea    
Schedule of Revenues from External Customers [Line Items]    
Total revenue 246,616 250,385
Other    
Schedule of Revenues from External Customers [Line Items]    
Total revenue $ 387,981 $ 266,601
v3.25.4
Other Income (Expense), Net - Schedule of Components of Interest and Other Income (Expense), Net (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Other Income and Expenses [Abstract]    
Interest income $ 17,433 $ 35,721
Gains on assets related to deferred compensation plan 13,773 19,638
Foreign currency exchange gains (losses) (5,828) 63
Other, net 13,344 (5,005)
Total $ 38,722 $ 50,417
v3.25.4
Income Taxes - Schedule of Provision for Income Taxes and Effective Tax Rates (Details) - USD ($)
$ in Thousands
 3 Months Ended
Jan. 31, 2026
Jan. 31, 2025
Income Tax Disclosure [Abstract]    
Income before income taxes $ 79,053 $ 291,117
Provision (benefit) for income taxes $ 14,337 $ (6,294)
Effective tax rate 18.10% (2.20%)
v3.25.4
Income Taxes - Additional Information (Details)
$ in Millions
 3 Months Ended
Jan. 31, 2026
USD ($)
Taxes [Line Items]  
Statutory federal income tax rate 21.00%
Minimum  
Taxes [Line Items]  
Estimated potential decrease in underlying unrecognized tax benefits $ 0.0
Maximum  
Taxes [Line Items]  
Estimated potential decrease in underlying unrecognized tax benefits $ 28.0